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ABSTRACT OF THE DISSERTATION 
Leveraging the Photothermal Effect for Cosmetic Applications 
by 
Wangzhong Sheng 
 
Doctor of Philosophy in Materials Science and Engineering 
University of California, San Diego, 2017 
Professor Adah Almutairi, Chair 
 
 
The photothermal effect is a phenomenon in which matter absorbs light energy 
and converts it into heat. This process can be leveraged to enable the application of 
light for biological applications, especially for otherwise benign light with 
wavelengths in the “optical window” regime of the electromagnetic spectrum between 
700-900 nm that can penetrate deeply into tissue. The objective of this dissertation 
work was to apply and adapt the photothermal effect in the context of cosmetic 
 xxi 
 
surgery in a safe and effective manner to aid in fat removal during liposuction. This 
thesis begins with a discussion of an area in which the photothermal effect has been 
applied extensively in biology, specifically, for the eradication of cancer, called 
photothermal therapy. Materials used for this application, known as photothermal 
agents, are briefly introduced. Light-matter interactions, including a variation of the 
photothermal effect called selective photothermolysis, are discussed in detail. Chapter 
One introduces an example where the photothermal effect was observed to be the key 
underlying mechanism enabling the release of encapsulated payloads from inherently 
non-light responsive polymer particles in the context of drug delivery. In Chapter 
Two, starting from basic engineering principles, specifically the heat equation, the 
photothermal effect is derived and mathematically modeled. Subsequently, the ability 
to achieve selective and confined photothermal heating in a target pigmented region 
was tested in a physical model involving a thermoresponsive polymer as an indicator 
to allow for simple visualization. After successful demonstration of these concepts, 
parameters such as photothermal agent concentration and manner of light exposure 
were optimized, and subsequent studies were performed in an ex vivo porcine tissue, in 
an in vivo porcine model, and finally, in an ex vivo human adipose tissue liposuction 
model. This work culminated in a single-blind study in human adipose tissue 
comparing photothermally assisted liposuction (dubbed NanoLipo), to a control 
involving saline injection and near infrared light laser-assisted liposuction absent gold 
nanoparticles. The results achieved in this work demonstrate the significant potential 
of this promising technology in making a clinical impact. 
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Introduction: 
 
A Review of the Progress towards Achieving Heat Confinement: the Holy 
Grail of Photothermal Therapy 
 
I. ABSTRACT  
Photothermal therapy (PTT) involves the application of normally benign light 
wavelengths in combination with efficient photothermal agents that convert the 
absorbed light to heat to ablate selected cancers. The major challenge in PTT is the 
ability to confine heating and thus direct cellular death to precisely where 
photothermal agents are located. The dominant strategy in the field has been to create 
large libraries of photothermal agents with increased absorption capabilities, and to 
enhance their delivery and accumulation to achieve sufficiently high concentrations in 
the tissue targets of interest. While the challenge of material confinement is important 
for achieving “heat and lethality confinement”, this review article suggests another 
key prospective strategy to make this goal a reality. In this approach, equal emphasis 
is placed on selecting parameters of light exposure, including wavelength, duration, 
power density, and total power supplied, based on the intrinsic properties and 
geometry of tissue targets that influence heat dissipation, to truly achieve heat 
confinement. This review highlights significant milestones researchers have achieved, 
as well as examples that suggest future research directions, in this promising 
2 
 
 
technique, as it becomes more relevant in clinical cancer therapy and other non-cancer 
applications. 
II. INTRODUCTION  
Cancer, characterized by uncontrolled cellular growth, is one of the leading 
causes of death in the United States.
1
 Nearly 1.7 million newly diagnosed cases of 
cancer were reported in 2015, of which about 35% of affected patients died from the 
disease.
2
 Since cancer incidence rates track closely with our growing aging population, 
these numbers are expected to continue to increase in the future. Cancer is not just one 
disease; it is extremely complex and can be found in many forms. Through continuous 
and enormous effort, we have gained a better understanding of cancer, although there 
is still much we do not know. What is clear is that cancer treatments almost 
universally require a multi-pronged approach to improve overall disease prognosis.
3-5
 
Currently, the primary prong of cancer therapy is surgery, which is often 
complemented by the sub-prongs of chemo
6
 and radiation therapy
7
 to bolster 
effectiveness. Nevertheless, resistance to treatment often leads to cancer recurrence, 
especially in the cases of certain malignant cancers.
8
 Additionally, the highly invasive 
nature, limited indication and success, substantial cost, and pain of surgery, as well as 
potential complications with expected and unexpected side-effects of adjuvant 
therapies, all lead to reduced quality of life and reduced life expectancy for surviving 
patients.
9-11
 Photothermal therapy (PTT) has recently emerged as a potential area of 
promise for this multi-pronged approach to cancer therapy.
12-16
 In PTT, the core 
concept is to apply otherwise benign near infrared (NIR) light that can reach several 
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centimeters beneath the skin surface
17
 in combination with highly efficient 
photothermal (PT) agents placed non-invasively within tissues to create hypothermia 
to damage cancers only where the agents are placed, offering unprecedented safety, 
specificity, and selectivity, in eradicating cancer.  
Historically, hyperthermia through heating has proven to be extremely 
effective in inducing damage, especially to biological tissues.
18
 In general, there is a 
time-temperature dependent relationship such that the higher the temperature, the 
more rapidly the tissues become damaged, with the likelihood of damage 
exponentially doubling above 43 °C.
19
 In tumors, the capacity for heat dissipation is 
significantly reduced due to the tortuous blood vessel network the cancers form, 
making them even more susceptible to thermal treatments.
20
 Despite this difference, 
care must be taken to precisely define where the heating occurs so that the surrounding 
healthy tissue is not accidentally damaged in the heating process. This concept is 
called heat confinement, and is often not achievable with traditional heating 
methods.
21
 Light-induced heating with the aid of PT agents has the advantage of 
affording more control over where the selected tissue heating occurs. However, the 
general drawback of poor tissue penetration-depth in light-based biological 
applications still must be overcome. Thus, the overall problem of selectively 
delivering heat to, and confining it within tissues, is one of the major challenges of 
photothermal therapy. 
In order to achieve light-induced heat confinement, highly efficient PT agents 
must first be sequestered inside the tumor at sufficient concentrations to absorb the 
deep-penetrating NIR light. Early incarnations of PTT involved the direct injection of 
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concentrated mixtures of PT agents into tumor xenografts followed by continuous and 
long-term exposure to high powered lasers.
13, 15, 22
 These initial outcomes often caused 
non-selective and uncontrolled heating to extreme temperatures, not unlike that of 
direct heating methods. These treatments resulted in immediate cellular death of both 
cancerous and non-cancerous tissues in the exposed regions. The mechanism of 
damage was that of well-known tissue hyperthermia, dominated by necrosis 
accompanied by irreparable denaturation of proteins and other biological 
macromolecules.
23
 While some of these proof-of-concept models demonstrated the 
ability of PTT to reduce tumor volume or prolong the survival of treated animals,
24
 
clinically, they are generally not feasible or practical. Additionally, as is usually the 
case with introducing any foreign substance into biological systems, it is also 
important to mitigate any potential toxicity associated with these exogenous agents.
25, 
26
 This will be no easy feat, and will likely require careful consideration of the multi-
factorial interactions between diverse and complex disease states found in cancer 
biology with the various engineered nanomedicine platforms delivering the cancer 
therapies. Thus, the delivery of PTT agents to the desired targets of interest is a second 
major challenge.  
This review focuses on the current state of development of this promising 
technology over many years, its recent advances, as well as obstacles that must still be 
overcome. We begin by introducing the theory behind the photothermal conversion 
process and examining examples where the photothermal effect was successfully 
applied towards heating of naturally existing pigments. In this context, the principle of 
selective photothermolysis is presented, where specific parameters of light exposure 
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are chosen based on the size and geometry of biological targets of interest to achieve 
heat confinement in pigmented tissues. We propose this principle as a strategy to 
potentially achieve more selective light-induced heat confinement in PTT. Some of the 
leading, highly efficient, man-made photothermal agents that enable this technique are 
then summarized, although we opted to take a succinct approach due to the vast 
amount of research published on this topic. We also briefly comment on the potential 
sources of toxicity of popular photothermal agents as well as strategies that have been 
employed to address these concerns. In the subsequent section, we expand on the topic 
of drug delivery and provide an overview of cases in which the PT effect was 
leveraged synergistically with diagnostic or other therapeutic agents, to garner 
theranostic or multi-modal therapeutic nanomedicine platforms, respectively, for 
cancer therapy. Finally, we speculate on critical avenues for further research and 
development that could make this technique more clinically relevant. 
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Figure 0.1. Schematic highlighting factors crucial to achieving material and heat 
confinement in photothermal therapy; Current research directions involve alternative 
parameters of light exposure to modulate tissue heating, or alternative methods of 
delivery, such as intravenous or local sustained-delivery, as opposed to bolus 
intratumoral injections that are typically considered the norm in photothermal therapy. 
Abbreviations: (Application of Laser Light) λ = wavelength, W/cm2 = power density,  
t = exposure time; (Prospective Photothermal Agents) ε = extinction coefficient, c = 
concentration, η = photothermal conversion efficiency. 
 
III. LIGHT TISSUE INTERACTIONS 
The interaction of light with matter is extremely complex.
27-31
 In general, when 
light impinges on matter, it interacts with the electromagnetic field of the atoms in the 
material and as a result, many complex phenomena occur. The interaction depends on 
important factors such as the wavelength and power density of light, but just as 
importantly, it depends on the properties of the interacting species itself. Different 
species can reflect, diffract, polarize, absorb and disperse light. Additionally, many 
complex nonlinear optical effects may occur.
30
 Nevertheless, in describing the PT 
effect, especially in diffuse anisotropic media such as biological tissue, many of these 
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observed phenomena can be categorized as absorption or scattering.
32, 33
 
Simplistically, absorption describes the amount of incident energy that is captured, 
whereas scattering describes any energy that is not.
33-35
 Absorption can be further 
distinguished into absorption by the target species or by unwanted species. Light 
which is competitively absorbed or scattered is said to be attenuated, or reduced in 
intensity. Additionally, depending on the PT absorber, not all of the electromagnetic 
energy may be converted to heat. For example, instead it could be used to drive 
chemical reactions in applications such as photodynamic therapy.
36, 37
 Absorbed light 
may also be re-emitted as another wavelength of light, e.g. fluorescence.
38, 39
 Good PT 
agents will not only capture a large percentage of the incident light, but also 
effectively transform it into heat, and are said to have high PT conversion 
efficiencies.
40-42
  The most commonly used model to describe absorption is the Beer-
Lambert law
43
:  
𝐴𝜆 =  𝜀 𝑐 𝑙 
where Aλ is the absorption (optical density) of the material at wavelength λ, ε is the 
molar extinction coefficient, c is the molar concentration, and l is the path length that 
the light travels through the absorbing medium. The Beer-Lambert law is quite 
accurate in describing light-matter phenomenon in cuvette settings,
44
 although actual 
observed behavior starts to deviate from this law if any major assumptions are not met. 
Unfortunately, biological tissue is one such medium. It contains several non-
independently absorbing pigmented species that may competitively absorb incident 
light in the highly inhomogeneous and turbid tissue environment.
45, 46
 Therefore, the 
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expected trends defined by this equation should only serve as a general reference when 
assessing absorbers for photothermal applications.  
The Biological Optical Window 
One of the biggest limitations in light-based biological applications is 
penetration depth.
47-49
 The strongest naturally existing species contributing to light 
attenuation by surface tissues are melanin, hemoglobin, and water.
50
 Melanin is a 
pigmented protein produced by melanocytes concentrated in the basal layer of the 
epidermis.  Melanin has a local absorption maximum around 350 nm that decreases 
gradually progressing into the visible wavelengths of the electromagnetic spectra and 
beyond.
51
 As a result, longer wavelengths of light can penetrate deeper into tissues. 
The amount of melanin in skin varies across different populations of people, and 
increases with sun exposure.
52
 Melanin content in skin is typically classified by the 
Fitzpatrick Scale of skin colors, with level I being very pale through level VI being 
very dark.
53, 54
 In all skin types, some of the penetrating light energy is absorbed by 
melanin. In darker skin types, melanin is present in significantly higher concentrations 
so even longer light wavelengths will have difficulty penetrating beyond the 
epidermis.
43, 44
 
Like melanin, hemoglobin also exhibits large absorptions at longer 
wavelengths, with a sharp drop at approximately 600 nm for both the oxygenated and 
deoxygenated forms.
55
 Dragan et al. measured the absorption of whole human blood 
sandwiched between two glass slides and found that at 800 nm, the absorption of a 1 
mm thick sample, which could be representative of a small blood vessel, was 0.5 
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optical density (OD).
56
 Described in terms of the Beer-Lambert law, this optical 
density means that nearly 70% of incident light is absorbed. Fortunately, hemoglobin’s 
contribution to light attenuation is more variable than melanin’s, since its absorption is 
dictated by the size and number of blood vessels, which, generally, are distributed 
non-homogenously in any given tissue. Thus, it appears that longer wavelengths of 
light beyond 600 nm would be preferred for transcutaneous biological applications.  
However, there exists an upper limit of around 1,000 nm, where another 
strongly absorbing “pigment”, water,57 can significantly limit light penetration into 
tissue. Since human epidermis is on average 64.6% water,
58, 59
 in addition to being the 
primary harbinger of melanin, it is the largest barrier to entry for light in the infrared 
regime of the EM spectrum. Because of this, techniques that have shown promise in 
achieving heat confinement, such as laser interstitial thermal therapy (LITT), a 
minimally invasive, contrast-agent-free, laser photothermal technique that relies on 
absorption of water-resonant wavelengths of light by the water molecules in tissue to 
directly ablate benign and malignant lesions, requires the percutaneous insertion of a 
fiber-optic catheter directly into tissues to bypass the skin barrier to achieve 
therapeutic efficacy.
60
 It would be desirable to be able to use wavelengths of light that 
can more readily bypass the optical skin barrier. Incidentally, when the absorption 
profiles of melanin, hemoglobin, and water are overlaid, a region of minimal 
absorption between 600 nms and 1000 nms emerges. This range of wavelengths is 
commonly referred to as the biological optical window (Fig. 0.2).
61, 62
 Light in the 
middle of this near-infrared (NIR) region (around 800 nm) can penetrate through skin 
10 
 
 
and up to several centimeters into tissue,
17
 making NIR absorbing species especially 
attractive for transcutaneous photothermal applications.
39, 63
  
 
 
Figure 0.2. A. Wavelengths between 700-900 nm are minimally absorbed by 
endogenous species and are able to penetrate deepest into tissue.
49
 Reproduced from 
Avci P et al. Low-level laser (light) therapy (LLLT) in skin: stimulating, healing, 
restoring. Seminars in cutaneous medicine and surgery. 2013;32(1):41-52. © 2013 B. 
Schematic demonstrating underlying principles behind laser hair removal 
technologies. Reproduced from Dr. Gayne Dolyan Descornet, “How does laser hair 
removal work”, Woman Health and Life.  C. Thermal relaxation times (TR) for 
spherical structures, e.g. tumors, of various sizes, according to selective 
photothermolysis theory. Treatment times in PTT are typically well above this regime. 
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Selective Photothermolysis to Overcome Attenuation by Endogenous Species 
Although endogenous species are responsible for the limited penetration depth 
of light, they have also been successful targets of photothermal applications in the 
tangential field of cosmetics. Photothermal targeting of melanin, in the form of laser 
hair removal,
64, 65
 and photothermal targeting of hemoglobin, in the treatment of port-
wine stains
66
 and varicose veins,
67, 68
 and have been widely and successfully applied in 
the clinic for decades. These applications take advantage of the fact that in biological 
structures such as hair follicles and blood vessels, there is a locally higher 
concentration of melanin and hemoglobin respectively, than is present within 
surrounding tissues. If the targeted structure absorbs the defined wavelength at least 
twice as much as its immediate surroundings, it is possible to selectively heat the 
target structure to damage it by optimizing the way in which light energy is applied to 
achieve heat confinement. Cooling of the skin surface can help to counteract some of 
the heating of the melanin, especially in darker skin types, to allow for the 
preservation of the sensitive dividing epidermal cells in the basal skin layer, while the 
deeper hair shafts are heated much more, relatively. In general, for transcutaneous 
applications, the higher the difference in absorption between the target structures and 
the surrounding tissues, including the skin, the easier it is to achieve heat confinement. 
This process, first proposed by R.R. Anderson,
69, 70
 is known as selective 
photothermolysis (SPT).  
In SPT, light is applied in a controlled pulsatile manner over a large region. 
Here, the strongly absorbing target structure will heat up much more than surrounding 
less-absorbing structures. The time it takes for the target structure to exponentially 
12 
 
 
decay from the maximum temperature reached is described by the thermal relaxation 
time, τR, which is dictated primarily by the size, geometry, and local density of the 
target structures. A core concept in SPT is to apply short, repeated bursts of light 
energy absorbed preferentially by  the target structures before heat can dissipate or 
diffuse to adjacent tissues (relaxation), resulting in the continual build-up of heat, 
thereby creating a selective-heating effect. The overall exposure time should be less 
than the thermal relaxation time of the target structure to ensure that the surrounding 
areas experience only mild temperature elevations. Another caveat is that pulses must 
not be too short in order to avoid any cavitation effects which may be induced by the 
high powers achieved as a result of the short pulses.
71
  
Heat transfer within tissues is governed by intrinsic properties of tissue such as 
thermal diffusivity, which is on the order of 10
-3
 cm
2
/s. Approximating this term to be 
the same for both the target and its surroundings, Anderson et al. calculated the τR for 
spherical targets with a wide range of sizes. For example, a spherical structure 1 mm 
in diameter has a τR of 0.3 seconds
69
. By taking into consideration other intrinsic 
properties of tissue such as density and specific heat, appropriate powers and durations 
of light exposure could be calculated for SPT of target structures of various shapes and 
sizes (Fig. 0.2).
70
 Altshuler et al. later expanded on this theory and proposed that due 
to the inexactness of the estimates, in practice, a buffer zone slightly larger than the 
absorbing structure should be defined with a threshold temperature set at this 
boundary that should not be exceeded. These engineering principles formed the 
foundation, and continue to serve as the guiding principles for the development of 
laser–based cosmetic technologies.72 
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Although SPT applied towards endogenous species does not overcome the 
problem of penetration depth, the unique ability to confine heat to specific targetable 
pigmented structures, while sparing the surrounding tissue, could prove extremely 
powerful in the context of practical photothermal therapy. In the case of photothermal 
heating of exogenous species, the major advantage, and challenge, is that one could 
create an absorbing structure by virtue of where the photothermal absorber is 
introduced. If we examine the optical aspects and apply the principles of SPT theory 
towards PTT, we find that in the majority of demonstrations of photothermal therapy, 
heating is rarely confined. Researchers typically continuously expose target regions to 
high laser powers, resulting in uncontrolled damage leading to necrosis of the treated 
region and beyond.
73
 Instead, we might propose that the thermal relaxation time could 
be estimated for different sized target tumors or metastases to determine the optimum 
parameters that should be used to limit the extent of photothermal heating and improve 
the specificity of PTT. Extending Anderson’s calculations further, spherical structures 
2 cm and 3 cm in diameter would have τR of approximately 2 and 5 minutes, 
respectively (Fig. 0.2). SPT for structures of any larger sizes may not be as applicable 
since rarely do tumors studied in a research setting exceed this size, and tumors of this 
size are likely to be resected clinically
74
. We have found examples in the literature 
where researchers have carefully considered how light is best applied based on the 
geometry of the target structures in order to maximize the specificity of the light-based 
application.
5, 16, 72, 75-77
 Furthermore, our own research lab is attempting to leverage 
this phenomenon in the context of liposuction to modulate heating of adipose tissues 
to aid in their removal by plastic surgeons.
72
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IV. PHOTOTHERMAL MATERIALS PLATFORMS 
Ultimately, the selective photothermolysis of tumors is enabled by the large 
differential light absorption between the target and the surrounding tissues. To that 
end, in this section we briefly summarize some of the leading man-made photothermal 
agents that have been applied for PTT.  
Exogenous Agents for Photothermal Therapy 
Many candidates have been explored for the photothermal killing of cancer 
both in vitro and in vivo (Fig. 0.3), with varying degrees of success. Arguably, the 
most widely applied class of photothermal agents is gold-based nanostructures, whose 
synthesis, characterization, standardization, and diverse properties have been 
extensively studied.
78-84
 The mechanism of light-to-heat conversion is a localized form 
of surface plasmon resonance (LSPR).
85
 This process is extremely efficient, and as a 
result, these materials exhibit one of the highest extinction coefficients reported,
86, 87
 
on the order of 10
9 
M
-1
cm
-1
. Since the absorbing LSPR peak and PT conversion 
efficiency are strongly dependent upon the geometry of the nanostructure,
88
 
researchers have engineered gold nanoparticles of many shapes and sizes to absorb 
preferentially within the biological window regime for photothermal therapy.  
The simplest of all the geometries is probably the solid gold spherical 
nanoparticle. Around the early 2000s, the El-Sayed group synthesized and studied the 
plasmonic properties of solid gold nanospheres and found that although they were able 
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to control the particle’s LSPR peak by tuning its size, the peak was still less than 600 
nm,
89
 making it not practical as a candidate for PTT. To overcome this limitation, the 
group investigated the plasmonic properties of gold nanorods (AuNRs) and found that 
the anisotropic geometry of these nanostructures resulted in the establishment of a 
second LSPR peak corresponding to the longitudinal direction of the elongated rod-
like structure.
12
 Simulations suggested that by varying the aspect ratio of the nanorods, 
the LSPR peak could be precisely tuned to absorb a wide range of wavelengths in the 
NIR regime.
90
 It took several years for a reproducible technique to synthesize gold 
nanorods to be developed,
91
 and several more years before AuNRs were applied for 
photothermal therapy in an in vivo setting.
13
 In this study, Dickerson et al. 
demonstrated the ability of plasmonic photothermal therapy to treat cancer in a 
squamous cell carcinoma xenograft model. The authors injected AuNRs either 
intratumorally (abbrev: IT; 15 μL, ODλ=800 = 40) or intravenously (abbrev: IV; 100 μL, 
ODλ=800 = 120) followed by 10 min of laser exposure, and compared the outcome to a 
negative saline control. Both procedures outperformed the control with the authors 
observing a >57 % tumor resorption for the IT-injected group versus 25% for the IV-
injected group. However, the IV injected group, which likely relied on passive 
accumulation via the enhanced permeation and retention (EPR) effect
92
 for delivery, 
required twenty times more AuNRs in combination with a laser power density almost 
double that of the intratumorally injected group, yet resulted in less tumor destruction 
(25% vs 57%, respectively).
13
 This is not surprising, given that a recent analysis of the 
literature found that in less than 1% of the time did injected nanoparticles successfully 
penetrate solid tumors.
93
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Around the same time, the Halas and West groups utilized a slightly different 
approach to engineer gold nanoparticles which could absorb in the NIR regime in the 
form of gold nanoshells (AuNS). AuNS are created by depositing a thin layer of gold 
on a dielectric nanoparticle substrate, most commonly, silica.
94, 95
 Similar to nanorods, 
the LSPR peak of nanoshells could be controlled by tuning the thickness of the shell, 
with the absorption maxima of thinner shells more red-shifted than thicker shells.
96
 
Hirsch et al.. applied these 100 nm gold-silica nanoshells in an in vitro and in vivo 
setting for plasmonic photothermal therapy.
15
 In the in vitro study, the authors 
incubated human breast epithelial carcinoma cells in a serum-free medium containing 
4.4 x 10
9
 PEGylated nanoshells per milliliter. After one hour, nanoshells were rinsed 
away and a coherent NIR light source at 820 nm, 35 W/cm
2 
was used to irradiate the 
cells for seven minutes to induce photothermal damage. Compared to the area treated 
with the laser in the absence of nanoshells, the photothermally treated regions saw 
significantly more cell death. For the in vivo demonstration of PTT, 20-50 μL of gold-
silica nanoshells were intratumorally injected 5 mm into the tumor volume and 
subsequently exposed to 820 nm light at 4 W/cm
2 
at a 5 mm spot diameter for up to six 
minutes. The authors observed temperature elevations of 37.4 ± 6.6° C within 4-6 
minutes of light exposure which induced irreversible damage to the tumor. However, 
examination of the thermal profiles as a function of depth revealed that the maximum 
temperature elevation was found at just 1 mm below the skin surface, even though the 
nanoshells were injected 5 mm deep into the tumor.
15
 It is likely that the AuNSs were 
distributed throughout the injection site, so photothermal ablation of the surface 
17 
 
 
tissues with the high powers applied may have created a carbonaceous layer which 
would have exacerbated light attenuation as the photothermal treatment proceeded.
22
 
 
Figure 0.3. Examples of photosensitizers applied for photothermal therapy; A. 
Graphene,
97
 B. Indocyanine green-loaded polymer nanoparticles,
98
 C. Melanin-human 
serum albumin nanoparticles,
99
 D. Gold nanorods,
100
 E. Multi-walled carbon 
nanotubes,
76
 F. Gold nanocages,
100
 G. Gold nanostars,
101
 H. Gold nanoshells,
94
 and I. 
MoS2 nanoplates.
102
 A., B., D., E., F., I. are reprinted with permission from the 
American Chemical Society, © 2010, 2013, 2013, 2009, 2013, 2014, respectively. C. 
is reprinted from permission from John Wiley & Sons, Inc. © 2013. G. is not subject 
to U.S. Copyright. H. is reprinted with permission from The Royal Society of 
Chemistry. © 2015. 
 
Many more photothermal agents with large effective absorptions have been 
developed, albeit they faced many of the same challenges described above. In terms of 
plasmonic photothermal agents, additional nanostructures with exotic geometries have 
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been synthesized and studied, including gold nanocubes, nanotetrahedron, and 
nanoicosahedrons,
103
 nanocages,
104
 nanostars,
44, 101, 105, 106
 and nanohexatripods.
100
 
None-gold based plasmonic nanostructures such as quantum dots,
107
 porous palladium 
nanoparticles,
108
 and silver nanoparticles
109
 have also been developed for plasmonic 
photothermal therapy. In addition to plasmonic photothermal nanomaterials, carbon- 
based agents such as single-walled
110
 and multi-walled
76, 111
 carbon nanotubes,
112
 and 
graphene sheets,
97, 113-115
 which rely on the vibration of excited, delocalized sp
2 
electrons in the lattice of the carbon structure for heat generation,
76
 have also been 
developed. Various small-molecule organic dyes absorbing in the NIR window such 
as indocyanine green (ICG),
22
 cypate,
116, 117
 and porphyrins,
118, 119
 have also been 
applied for PTT. In the case of these agents, various engineered nanostructures such as 
micelles
14, 120-125
 and biopolymer-based nanoparticles
38, 126, 127
 need to be employed to 
prolong the residence time of the agents to make them applicable for PTT, because 
they are prone to photo-bleaching
128
 and are rapidly cleared from the body.
129
 
Sometimes, the polymer particles themselves can be applied directly as photothermal 
agents, as is the case with the conducting polymer, polypyrrole.
85, 130, 131
 Other creative 
researchers have even engineered melanin-loaded polymeric nanoparticles for use in 
PTT.
99, 132
 
The plethora of existing agents that have been reported can attest to the 
incredible amount of research effort dedicated to this topic. Unfortunately, there is 
inherent variability between different photothermal platforms relating to their intrinsic 
properties such as their extinction coefficients and PT conversion efficiencies, which 
are useful for determining the absorption cross-section of the agent used.
133
 However, 
19 
 
 
additional factors such as the wide range of laser parameters and the diverse cancer 
models used, must be considered just as carefully. As a result, a comparison between 
different photothermal agent platforms, or even across the same photothermal agent 
platform
82
 is difficult, and does not yield meaningful conclusions (Tab. 1). For this 
reason, we opted to abstain from summarizing these studies in detail. Instead, we 
chose to highlight a few key milestone examples, as well as some trends in the 
development of this technique in Tab. 1, some of which we have already discussed 
above.  
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Systemic Toxicity and the Challenge of Delivery 
Although novel agents are still being reported today, one issue that has 
persisted is the delivery of PT agents. PTT involving intratumoral routes of 
administration are still consistently outperforming intravenous ones. The necessity for 
direct injection into tumors can be problematic because of size, location, and the need 
to visualize the tumor and its borders with costly equipment, often in an operating or 
procedural room setting. Unfortunately, intravenous injection of PT agents, in addition 
to suffering from the disadvantage of poor accumulation in target tissues, also poses 
the potential problem of systemic toxicity. Recently, del Rosal et al. reported on the 
application of NdVO4 nanocrystals (NCs) for photothermal therapy.
134
 The authors 
observed an absorption cross-section of 2.0 x 10
-19
 cm
2
, which was eight orders of 
magnitude lower than gold’s reported absorption cross-section86 of 2.93 x 10-11 cm2. 
As a result, much more NCs were needed to achieve the desired absorption. The 
authors injected the NCs intratumorally at a concentration nearly 2,000 times the 
maximum amount which they showed to be safe in vitro in order to achieve minimal 
photothermal heating that was only slightly more (~8 °C)  than the laser-alone group 
after 4 minutes of laser exposure. If the IT injected amount was diluted by the whole 
blood volume of the animal, which would be the case if the agent had been injected 
IV, the concentrations reached would still be an order of magnitude above the 
documented safety threshold shown by the authors. We then have to consider whether 
the photothermal agent itself could induce acute toxicity, not to mention the challenge 
associated with administering such a large amount of material. Ultimately, the general 
determining factor for toxicity of foreign agents is whether the concentrations injected 
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are above the known acceptable thresholds for the therapeutic agents in question.
26
 
This means that PT agents with high absorptions but a low toxicity threshold could 
exhibit concerns, as well. 
In general one of the biggest concerns of nanoparticles is the fate of the 
nanoparticles after it is introduced into the body.
25, 26, 135
 Ideally, injected NPs, 
especially those of an inorganic nature, should be renally cleared, which means that 
their hydrodynamic radii need to be less than 5.5 nm.
136-139
 For this reason, the 
majority of IV injected inorganic nanoparticles are not approved by the FDA for 
systemic use clinically.
137
 Unfortunately, almost all of the useful inorganic 
nanoparticle-based photothermal agents studied are above this accepted size range. 
When Sonavane et al. investigated the biodistribution of gold nanoparticles of a broad 
size range (15 nm up to 200 nm), they found that 15 and 50 nm NPs were able to 
penetrate the blood brain barrier in mice.
140
 This result is alarming since the majority 
of gold nanoparticles used for PTT are in this size regime.
141
 Nevertheless, some 
studies have shown that gold nanoparticles induced no acute toxicity when uptaken by 
human cells.
142
  
The geometry of nanoparticles may also influence their biodistribution. Black 
et al. investigated biodistribution of gold nanostructures with varying shapes and 
found that gold nanorods and cages were distributed throughout tumors while 
nanospheres and nanodisks were only around the tumor periphery.
143
 In a similar 
study, Wang et al. found that nanohexapods exhibited even higher cellular uptake, and 
more importantly, lower cytotoxicity compared to nanorods and nanocages of similar 
sizes,
100
 suggesting that geometry may also be implicated in the potential toxicity of 
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nanoparticles. It is critical to ensure that injected nanoparticles are stable and 
structurally sound, especially because they can be easily heated to extreme 
temperatures due to their high effective absorptions. Recently, Goodman et al. 
reported on the surprising in vivo instability of hollow gold nanoshells (HGNS).
144
 
Although their HGNS were observed to be completely stable under laser irradiation in 
solution, biodistribution studies suggested that the nanoshells were heavily fragmented 
in vivo, with the authors attributing the cause of the instability to residual silver ions 
remaining after synthesis of the HGNS. The findings are in line with what other 
researchers have observed for gold nanorods, which are known to fragment or shorten 
upon exposure to high laser power densities, although smaller particles were found to 
be more resistant to fragmentation due to coupling to the environment.
108, 145
 Overall, 
these results are not unexpected, however, since systems often do not behave the same 
in aqueous dispersions as they do in vivo.
44
 From these examples, we see that 
inorganic nanostructures still face many challenges before they can be translated into 
useful clinical therapies.
146
 
Organic photothermal agents have not fared much better, mostly for the same 
reasons of biodistribution, stability, and toxicity related to processing.
25
 For example, 
the high aspect ratio of carbon nanotubes, reminiscent of the geometry of carcinogens 
such as asbestos, led to long-term residence in the lungs of mice studied.
147
  Residual 
metallic impurities from nanotube synthesis and undesirable aggregation are also 
commonly attributed to toxicity of carbon nanostructures.
135
 Various strategies have 
been employed to functionalize photothermal agents with passivating polymers. Most 
commonly, polyethylene glycol (PEG) is employed to impart a stealth-like character 
24 
 
 
to these agents to reduce their toxicity.
148, 149
 The attachment of targeting moieties to 
photothermal nanoparticle platforms for functional groups overexpressed in certain 
cancers may help improve the local accumulation of photothermal agents within the 
tumor to increase treatment specificity and hopefully their effectiveness, while also 
reducing their systemic toxicity (Tab. 0.1).
150
  
Finally, the challenges of systemic delivery could be avoided altogether, if 
local routes of administration were developed and perfected. Conde et al. recently 
reported on a well-characterized triple-combination photothermal, chemo, and gene 
therapy applied at the tumor location in the form of a hydrogel patch with or without 
tumor resection (Fig. 0.4).
77
 In their prophylaxis study without pre-resection, a 
hydrogel patch loaded with gold nanoparticles and nanorods was implanted 15 days 
after tumor induction, with multiple photothermal treatment events starting on day 18. 
The remarkable part of this study was in its methodology. Instead of choosing 
traditional PTT methods involving a single exposure at a high power density, the 
authors opted for multiple treatment events of short durations (120 s) applied once per 
day over the span of several days. Although the authors did not discuss their reasoning 
for the short exposure times, these times corresponded well, and likely not by 
coincidence, to the thermal relaxation times we calculated in Sec. 2 for the 
corresponding tumor sizes in this study. This prophylactic triple combination 
treatment, which is especially relevant for non-resectable tumors, was able to achieve 
complete tumor remission whereas the control group with tumor resection only saw 
40% tumor recurrence. Furthermore, treatment following intratumoral or systemic 
injection of the gold nanomaterials resulted in only 60% and 40% tumor reduction, 
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respectively. This result is consistent with most of the existing studies comparing IT 
and IV modes of administration.
151, 152
 Strategies such as this could help reduce the 
chance for systemic toxicity, although it would be important to ensure that the 
photothermal agents did not extravasate elsewhere. However, choosing known low-
toxicity agents with well-documented excretion pathways can obviate some of these 
concerns.  
 
 
Figure 0.4. A triple-combination local delivery platform developed by Conde et al. in 
which chemo, gene, and photothermal therapy are applied in conjunction to eradicate 
cancer. For the photothermal therapy component of the treatment, the authors 
performed four sessions of laser exposure for120 seconds each (1W, 808 nm) on days 
18, 19, 20, 25 to reach temperatures as high as 60 °C to damage colorectal cancer in a 
xenograft tumor model in mice.
77
 Reprinted with permission from Macmillan 
Publishers Ltd: Nature Materials; J. Conde, N. Oliva, Y. Zhang and N. Artzi, Nat. 
Mat. 15, 1128–1138 (2016), © 2016. 
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In this section, we saw that a significant amount of effort has been dedicated 
towards finding novel agents with high effective absorptions for photothermal therapy. 
However, the potential systemic toxicity of photothermal agents and their route of 
administration are factors which must also be carefully considered regardless of the 
effective absorption of the agent. In Sec. 2, we suggested one possible way the 
parameters of light exposure could be optimized is to limit the heating to tumors, 
while sparing surrounding tissues. In this section, we saw a recent example of 
researchers already moving forward in that direction. In the next sections, we discuss 
in more detail, how nanomedicine
153-156
 has helped, and may continue to help mitigate 
attenuation effects resulting from improperly introduced photothermal agents and 
address toxicity concerns
157, 158
.  
 
V. NANOMEDICINE ENABLED SYNERGISTIC PHOTOTHERMAL 
THERAPY PLATFORMS 
Photothermal therapy, as we have presented so far, involves light-induced 
heating to high temperatures with the assistance of strongly absorbing photothermal 
agents to ablate cancerous tissues. Apart from being used to directly ablate tumors 
cells, light induced heating is useful in many other processes related to cancer therapy, 
as well. In this section, we present some examples in which photothermal agents are 
integrated with other cancer therapeutic or imaging modalities to garner 
multifunctional theranostic nanoparticle delivery platforms to enhance the outcome of 
cancer treatment.  
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Benefits of Mild Hyperthermia 
Hyperthermia involves heating of biological tissues to none physiological 
temperatures. While temperatures above 43 °C are employed to ablate tissue, heating 
to milder temperatures could also prove to be beneficial in the context of cancer 
therapy.
159-161
 One of the first responses by the body to local hyperthermia is enhanced 
blood flow to the region to dissipate heat. As mentioned in Sec. 1, the tortuous nature 
of the improperly formed blood vessels found in tumors creates a selective mechanism 
for heat build-up. This property, combined with the typically lower threshold of tumor 
cells to tolerate heat, naturally make tumors more susceptible to thermal damage.
20
 
Increased blood flow also contributes to amplifying the EPR effect to enhance the 
amount of material accumulating in the tumor,
162
 such as circulating photothermal 
agents or chemotherapy drugs, perhaps all loaded into and delivered by a single 
nanoconstruct. Mild temperature elevations may also trigger subcellular events to 
render cells susceptible to damage through apoptosis.
23, 111, 161, 163
 In addition, it may 
drive a shift towards anaerobic metabolism in cells, resulting in higher oxygen 
availability to the tissue environment to overcome the hypoxic conditions typically 
found in tumors that have limited the efficacy of oxygen-dependent cancer 
therapies.
131, 164
 Unfortunately, one major undesirable heating-associated effect is the 
activation of immunological responses, including the upregulation of heat shock 
proteins (Hsp)
165
 that lends itself to protecting cancer cells from being damaged.
166, 167
 
In fact, studies have shown that the ability of cancers to upregulate Hsp production is 
well-correlated with the aggressiveness of the cancer,
165
 resulting in various gene 
therapy-based strategies to block Hsp production to improve cancer treatment 
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outcomes.
117, 168
 Nevertheless, by integrating photothermal capabilities into theranostic 
nanoparticle platforms, researchers could use the mild heating regime to initially 
amplify the efficacy of other treatment modalities, followed by controlled 
photothermal ablation at higher laser power densities, creating a two-pronged attack, 
to help to ensure tumor destruction. 
Photothermally Triggered Payload Release 
Controlled drug release is important in cancer chemotherapy because it enables 
potent chemotherapeutic drugs to kill the cancers while minimizing systematic 
toxicity. Many physical, chemical and physiological signals have been explored to act 
as triggers for controlled release of chemotherapy drugs. As discussed previously, 
light is a unique trigger but is still limited by the availability of effective 
photochemical processes. In addition to synergistic enhancement of other therapies, 
heating, generated by photothermal agents with the irradiation of light, can expand the 
utility of light-controlled release to non-photoresponsive systems. In general, various 
drug carriers such as liposomes,
169
 polyelectrolyte capsules, polymeric nanoparticles,
75
 
and even blood-cell-mimicking capsules
170
 all become less stable and more permeable 
upon heating, leading to the therapeutic cargo eluting from their interior. Moreover, 
the burst nature of heating-induced release can effectively enhance the efficacy of 
treatments such as chemotherapy in the appropriate environment. Following this 
concept, various studies using laser-triggered controlled release systems involving 
photothermal transducers and thermoresponsive systems or phase-changing materials 
as release substrate have been demonstrated.
98, 171, 172
 In one example, Kim et al. 
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reported an elegant system utilizing gold nanoshells for the photothermally-triggered 
cargo release. They first load the cargo into liposomes and encapsulate the liposomes 
with a thin layer of the nanoshells. The integrity of the AuNSs make the liposome 
leakage-free under ambient conditions. Upon the exposure to NIR light, the gold 
nanoshells generated heating via the photothermal effect and deform in situ, triggering 
the release of cargo from the interior.
173
 In a similar example, Zheng et al. designed a 
synergistic chemo/photothermal therapy platform containing the common 
chemotherapy agent, doxorubicin (DOX), and ICG loaded into a lipid-polymer 
nanoparticle system (DINP).
98
 The authors showed that the DINPs were stable in the 
absence of light, but with a single, eight-minute treatment of 808 nm laser at 1 W/cm
2
, 
they were able to trigger the release of DOX and also heat the tumor to more than 50 
°C to ablate it. Compared to the all of the controls, the DINPs were the most effective 
and seemed to be the only system able to suspend tumor growth for up to 17 days. 
Although not applied to cancer, our own research group recently demonstrated the 
exciting potential for using selective photothermal heating of water nanodomains 
confined inside non-light responsive polymer microparticles, as a means to induce 
payload release.
75
  
Photothermally Enhanced Cellular Uptake 
Photothermal heating could also be leveraged to increase cellular uptake, as 
well.
174
 It is known that many nano-sized objects are uptaken by cells via receptor-
mediated endocytosis, macropinocytosis, and other membrane-related processes. A 
number of studies have shown that the permeability of cell membrane can be 
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significantly enhanced when the environmental temperature is increased to 43 
o
C, 
resulting in the uptake of more therapeutic agents in the targeted regime.
175
 Provided 
that most therapeutic agents require a minimum concentration to be effective, 
enhancing localized uptake to cells may potentially increase the utilization percentage 
of delivered therapeutic agents, while lowering the overall dose that needs to be 
administrated.
44
 Following this concept, Sherlock et al. demonstrated that ultra-small 
iron-cobalt (FeCo)-core-graphitic-carbon-shell nanoparticles loaded with the DOX 
exhibited accelerated cellular uptake upon NIR laser irradiation.
176
 Particularly, the 
FeCo-graphitic-shell nanoparticles with a large absorption band can heat the targeted 
cells from 37
o
C to 43
o
C at laser power densities as low as 0.3 W/cm
2
. The 6 
o
C 
incremental temperature increase in the cell media induced a two-fold increase in the 
cellular uptake of the FeCo-graphitic-shell nanoparticles loaded with DOX. Similarly, 
Tian et al. showed that the uptake of nano-graphene, which has proven to be an 
effective carrier for gene transfection without any other aids, can be enhanced three-
fold with NIR exposure.
113
 The Lapotko group also demonstrated an intriguing 
pathway of applying the photothermal effect for enhanced drug delivery. They found 
that plasmonic noble metal nanoparticles exposed to short laser pulses could generate 
transient vapor bubbles which could adhere to cell membranes and disrupt them upon 
the burst of these bubbles. The authors demonstrated that the burst event can be either 
used as trigger for drug release from the carrier or to enhance endosome escape of the 
engulfed drugs.
177
 These strategies to enhance cell membrane permeability are 
promising, and are likely to become more popular in translational nanomedicine 
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research because many of the drug delivery vehicles could be engineered to have these 
capabilities. 
Combination Photo-therapies 
Combinatorial therapies which integrate several therapeutic approaches 
together, such as the PTT/Chemotherapy system described above,176 have generally 
proven to be more effective than stand-alone techniques.178 Photodynamic therapy 
(PDT) is an oxygen-dependent light-based cancer therapy very similar to PTT in 
which photosensitizer molecules transfer the energy of the absorbed photon to the 
surrounding molecular oxygen to locally generate toxic singlet oxygen molecules, 
instead of heat, resulting in local toxicity to effectively damage the structure and 
function of cancer cells. Like PTT, PDT has many of the same advantages of high 
specificity and low systemic toxicity compared to conventional chemotherapy. 
However, an inevitable drawback that has hindered the efficacy of PDT in tumor 
treatment is its requirement for oxygen. The hypoxic conditions found inside tumors 
are exacerbated by the depletion of the already limited oxygen supply from the 
oxygen-consuming reactions of PDT. It is also important to isolate PDT agents inside 
drug delivery vehicles because these highly sensitive species could become toxic with 
exposure to even ambient levels of light.
179
 Nevertheless, due to the high level of 
similarity between PDT and PTT, it made sense to design systems with both modes of 
therapy integrated. Jang et al. demonstrated an interesting example by using gold 
nanorods as both carrier and quencher for the PDT agent, aluminum phthalocyanine 
tetrasulfonate (AlPcS4). AlPcS4 was assembled onto the surface of gold nanorods and 
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quenched by the surface plasmon resonance. Therefore, they were non-phototoxic 
even when exposed to light of proper wavelengths. Only when the gold nanorods were 
used to generate heat under laser irradiation were the photosensitizers released from 
the surface, thus becoming phototoxic. In a similar example, gold nanostars were 
surface functionalized with another PDT agent, chlorin e-6, to perform dual 
PDT/PTT.
105
 In concept, PDT initially performs according to its design parameters 
due to the presence of oxygen, but as oxygen becomes depleted, PTT takes over as the 
predominant mode of tumor damage, and in combination, conspires to doubly damage 
the tumor.   
Photothermal Therapy/Photoacoustic Imaging 
Adding diagnostic functions to nanoparticle drug delivery systems can be 
useful for tracking their location, as well as help provide information and feedback 
regarding the therapy. Photoacoustic (PAc) imaging, a natural “derivative” of the 
photothermal effect, is likely the easiest to implement along with PTT because it 
utilizes the heat generated from laser irradiation to produce acoustic waves that can 
convey both the anatomic and functional information about the tissues probed.
180, 181
 
Huang et al. reported a biodegradable gold nanovesicle composed of a simple design 
comprised of PEG-b-PCL tethered to AuNPs for photoacoustic imaging and 
photothermal therapy, simultaneously, while under the irradiation of the same laser.
182
 
More recently, Yong et al. and Song et al. reported using WS2 quantum dots
183
 and 
two-dimensional Co9Se8
184
 nanosheets, respectively, as agents for both PTT and PAc 
imaging. These materials belong to a group of novel PT agents classified as metal 
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chalcogenides,
102, 185-187
 which exhibit broad absorption spectra, high extinction 
coefficients, and photothermal conversion efficiencies, as well as low cytotoxicity.
188
 
Moreover, these nanostructures can be easily functionalized to enable other popular 
imaging modalities, such as fluorescence imaging, magnetic resonance imaging,
189
 
and computed tomography,
183
 without affecting the photothermal conversion process, 
thereby making them even more powerful as platforms for photothermal applications.  
 
 
Figure 0.5. Photothermal theranostic systems such as indocyanine-human serum 
albumin nanoparticles are capable of multi-modal imaging, as well as multi-modal 
therapy to allow for the tracking of the photothermal agents in conjunction with 
combination therapy to improve cancer treatment outcomes.
16
 Adapted with 
permission from the American Chemical Society © 2016. 
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VI. PROGRESS AND FUTURE PERSPECTIVES 
Case Study: ICG Then and Now 
Through the examples presented thus far, it is evident that photothermal 
therapy has progressed significantly since the idea of light-induced heating to kill 
cancer was first conceptualized. To provide some perspective, we present, to our 
knowledge, one of the earliest examples of photothermal therapy, or “chromophore-
enhanced tumor destruction”, as it was referred to in 1995 (Tab. 0.1).22 After having 
characterized their system in vitro,
190
 Chen et al. subcutaneously injected 0.5 to 1% 
indocyanine green in free dye form, into mammary fat-pad tumors of rats, exposed 
them to various laser power densities, and monitored the animals for up to 9 days. 
Several important conclusions were drawn from this study which reiterates many of 
the challenges for PTT presented thus far. First, the authors found that laser powers in 
the 3-5 W range worked unequivocally better than higher powers in the 10-15 W 
range, since the higher powers rapidly denatured and burned tissue, creating a 
carbonized tissue layer which effectively shielded NIR light from penetrating into 
tissue, suggesting that the parameters of light exposure must be carefully considered. 
Second, the authors conceded that the model showed efficacy, likely because 
intratumoral administration of the dye into the capsule-like tumor allowed the 
chromophore to be sequestered long enough to allow for photothermal treatment, 
suggesting that encapsulation, delivery, and accumulation of photothermal agents, 
especially small molecule dyes like ICG, via alternate routes of administration, might 
be critical to the success of PTT.  Lastly, the authors found that although tumor 
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destruction was apparent in their period of observation, a sufficient amount of tumor 
cells remained viable and was able to perpetuate the tumor growth in all of groups. A 
study extending out to 30 days revealed that at time of death, the laser-ICG treated 
tumors were still about half the size of tumors treated by lasers only
191
. This result 
suggested that PTT alone, at least as a single treatment, may not be sufficient in 
eradicating a tumor. Cancer has proven to be a complex and formidable challenge for 
medical sciences. Multi-pronged strategies involving therapies such as PTT at 
specified times and parameters, following surgical interventions such as reduction of 
tumor bulk combined with other modalities such as chemo, radiation, immunotherapy, 
and stem cell targeting, are likely needed to improve treatment outcomes. 
In this review we have highlighted significant advances in nanomedicine; over 
the past two decade, researchers in many fields have helped us understand and 
overcome many challenges. As an example, a simple yet elegant system, comprising 
ICG as the primary photosensitizer, was recently reported by Sheng et al. (Fig. 0.5).
16
 
Indocyanine green, in addition to being applied for PTT, and by extension, 
photoacoustic imaging, can also serve as a photosensitizer in PDT when exposed to 
low-power short-term laser exposures.
192, 193
 The authors attached ICG to human 
serum albumin (HSA) using thiol chemistry, and the system subsequently self-
assembled into a theranostic nanoparticle platform (HSA-ICG NP).
16
 By formulating 
ICG into NPs, they were able to enhance its uptake into cancer cells in addition to 
improving the stability of the dye in terms of its rapid clearance and photo-bleaching, 
while also enabling fluorescence imaging. The authors intravenously injected the 
HAS-ICG-NPs and in terms of imaging, were able to track the NPs through dual 
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PAc/fluorescence imaging. In terms of therapy, they were able to deliver the ICG-NPs, 
as well as achieve dual PDT/PTT, by applying an 808 nm laser continuously for 5 min 
at 0.8 W/cm
2
.
 
In the xenograft model, this combined therapy was able to completely 
destroy the tumor and ensure the survival of all the animals in the study group, out to 
50 days, while only stunted tumor growth was observed in all of the control groups 
(particles alone, laser alone, or interval exposure), with no animals surviving beyond 
25 days. Interestingly, when the same study was carried out in an orthotopic tumor 
model with the same type of cancer (4T1 breast carcinoma), interval exposure was 
able to prolong the survival of the animals an additional 10 days, out to 35 days, while 
other control groups of particles alone or laser alone performed about the same as the 
xenograft study, demonstrating at least some degree of effectiveness akin to selective 
photothermolysis with interval exposure. The reduced effectiveness for the interval 
group compared to the continuous exposure group could be attributed to the long rest 
times between exposure events (1 min exposures with 5 minutes rest intervals) in the 
interval exposure group. Overall, compared to the work by Chen and colleagues, this 
work involved only a single photosensitizing agent, and it was still able to accomplish 
tumor destruction through dual-therapy, and also provide diagnostic information by 
tracking the injected nanoparticles. 
 
VII. CONCLUDING REMARKS 
The development of various engineered NIR-light-absorbing nanoscale agents 
will continue to attract attention in the field of cancer therapy and beyond. In this 
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review, we presented many examples of how photothermal therapy has incrementally 
evolved over the years. The idea of applying the photothermal effect to treat cancer 
arguably arose from the desire to expand upon the therapeutic benefits of mild 
hyperthermia therapy. As vast libraries of powerful photothermal agents were 
developed, PTT research deviated from mild hyperthermia therapy and evolved into 
ablation therapy, where high laser powers were used to heat up these highly efficient 
agents to uncontrollably damage tissue. However, as researchers began to understand 
the implications of uncontrolled heating, attention began to shift towards carefully 
controlling the light-exposure to achieve more defined thermal damage. There was 
also a shift back towards applying the photothermal effect to achieve mild 
hyperthermia to synergistically bolster other treatment modalities in cancer therapy. 
Although our review is far from being exhaustive, present efforts support this claim, 
and indicate continued development and refinement of some of the more complex 
theranostic photothermal platforms incorporating photothermal agents of all types for 
use in multiple imaging and therapeutic applications. The addition of targeting 
capabilities to improve accumulation of nanoparticle therapeutic platforms within 
tissues of interest, as well as selective heat confinement through controlled light 
exposure, are strategies vital to expanding the ability of this platform to assist 
preclinical and clinical research. The field of nanomedicine has helped tremendously 
on the material-confinement front. Looking forward, careful manipulation of the 
parameters of light exposure, perhaps through concepts borrowed from selective 
photothermolysis theory, could push a shift in paradigm in this field that may one day 
lead to truly selective heating of tumors, which if achieved, would bring photothermal 
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therapy one step closer to becoming a vital prong in the clinical cancer therapy 
approach.  
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Chapter I: 
 
Near Infrared-Induced Heating of Confined Water in Polymeric Particles 
for Efficient Payload Release 
 
1.0 CHAPTER ONE PREAMBLE 
In this chapter, I describe my findings in a project involving light-activated 
release of various payloads from inherently none light-responsive polymer micro and 
nanoparticles. In a previous study investigating the use of light-sensitive polymers for 
the release of payloads from particles formulated by electro-spray, it was discovered 
that the control group involving microparticles comprised of poly-lactic-co-glycolic 
acid (PLGA), a none light-responsive polymer, released significant amounts of 
encapsulated payload in response to exposure to water-resonant wavelengths of light 
at 980 nm. Along with my collaborator, M.L. Viger, we explored this phenomenon 
further and discovered that nano-domains of water were formed as a result of the 
hydration process when microparticles were placed into an aqueous environment. 
These nanodomains of water not only plasticized the polymer and lowered its glass 
transition temperature (Tg), but were also preferentially heated upon exposure to light, 
inducing a rise in temperature to above the plasticized Tg of the polymer, leading to 
payload release. We found this mechanism to be highly universal, and to be applicable 
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for the release of payloads with a wide range of hydrophobic characteristics, as well as 
from a wide range of none light-responsive polymers.  
As is often the case, scientific discoveries such as this result from chance or 
perceived failures in preceding experiments. This chapter introduces the chance 
encounter that led to my first exposure to the photothermal effect, specifically, to a 
variation of selective photothermolysis that would form the underlying basis of this 
dissertation. The remainder of Chapter 1, below, is in full, a reprint of the material as 
it appears in ACS Nano 2014. Mathieu L. Viger, Wangzhong Sheng, Kim Doré, Ali 
H. Alhasan, Carl-Johan Carling, Jacques Lux, Caroline de Gracia Lux, Madeleine 
Grossman, Roberto Malinow, and Adah Almutairi, ACS Press 2014. The dissertation 
author and M.L. Viger were the primary co-investigators and co-authors of this 
manuscript and contributed equally. 
1.1 ABSTRACT 
Near-infrared (NIR) light-triggered release from polymeric capsules could 
make a major impact on biological research by enabling remote and spatio-temporal 
control over the release of encapsulated cargo. The few existing mechanisms for NIR-
triggered release have not been widely applied because they require custom synthesis 
of designer polymers, high-powered lasers to drive inefficient two-photon processes, 
and/or co-encapsulation of bulky inorganic particles. In search of a simpler 
mechanism, we found that exposure to laser light resonant with the vibrational 
absorption of water (980 nm) in the NIR region can induce release of payloads 
encapsulated in particles made from inherently non-photo-responsive polymers. We 
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hypothesize that confined water pockets present in hydrated polymer particles absorb 
electromagnetic energy and transfer it to the polymer matrix, inducing a thermal phase 
change. In this study, we show that this simple and highly universal strategy enables 
instantaneous and controlled release of payloads in aqueous environments as well as in 
living cells using both pulsed and continuous wavelength lasers without significant 
heating of the surrounding aqueous solution.  
1.2 INTRODUCTION 
Light-triggered release from polymeric particles is a key tool for delivering 
encapsulated molecules with a high degree of spatial and temporal control.
194-199
 
Given the deep penetration depth and low attenuation of near infrared (NIR) radiation 
in biological tissues, systems that respond to these wavelengths (750-1300 nm) are 
particularly attractive.
200
 Though many technologies facilitating release of 
encapsulated cargo from polymeric carriers using NIR radiation have been developed, 
all of them originate from only a handful of photochemical and photo-physical 
strategies, which present drawbacks that limit the extent of their application. For 
example, gold or other metal nanostructures are often incorporated to generate heat 
upon absorption of NIR light, loosening the surrounding polymer matrix to release 
therapeutics.
201, 202
 This approach is limited by the controversial biocompatibility of 
metal nanostructures and the considerable amount of heat generated that may be 
detrimental to surrounding tissues.
203-205
 Alternatively, carriers can also be formulated 
from polymers containing photo-responsive modalities that respond through chemical 
changes such as isomerization, oxidation, dimerization, and bond cleavage.
206, 207
 In 
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order to make use of the inherently low energy of NIR light, these mechanisms all 
require simultaneous two-photon absorption, necessitating the use of high-powered 
and focused pulsed NIR lasers, with energies sometimes exceeding the damage 
threshold of biological tissue.
208, 209
 Recently, the limitations of two-photon 
photochemistry have been overcome by coupling photosensitive polymer carriers to 
upconverting nanoparticles (UCNPs) that sequentially absorb multiple NIR photons 
and convert them into higher-energy photons in the UV region.
210, 211
 Since excitation 
photons do not have to be absorbed simultaneously, UCNPs could enable triggered 
release in response to more biologically benign power densities. However, UCNPs 
contain heavy rare-earth elements that may prove to be toxic in vitro and in vivo.
212
 
These significant barriers to widespread application encourage further work to 
discover metal-free, universal strategies for remote-controlled photo-release using NIR 
light. 
In search of such a mechanism, we found that exposure to NIR laser light 
resonant with the vibrational overtone of water at 980 nm (Figure 1.1A) could induce 
release of an encapsulated payload from particles made of inherently non-light-
sensitive polymers, e.g. poly(lactic-co-glycolic acid) (PLGA). We hypothesize that 
this universal release mechanism arises from the interaction between the 
electromagnetic radiation and confined nano-domains of water formed upon hydration 
of the particles (Figure 1.1B).
213, 214
 Upon exposure to 980 nm NIR light, water 
molecules absorb optical energy through vibrational transitions and the excitation 
energy is rapidly converted into heat.
215-217
 In the case of bulk water, the heat is 
rapidly dissipated through the whole aqueous environment via convective heat 
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transfer.
218
 However, for small water droplets trapped inside polymer microstructures 
and partially shielded from the external bulk water, the absorption of resonant 
electromagnetic energy increases the internal droplets’ temperature. To equilibrate the 
resulting temperature gradients, part of the generated heat is hypothesized to be lost by 
conductive heat transfer to the surrounding constituting matrix (Figure 1.1C), thus 
locally increasing the temperature of the polymer. Localized heating of the polymer 
matrix above the polymer’s glass transition temperature would induces a phase change 
from a rigid, glassy state to a compliant, rubbery state, activating diffusion of 
encapsulated payload out of the particles. 
Using real-time monitoring of steady-state fluorescence, we found that this 
strategy can be readily applied to precisely control the release of encapsulated contents 
of varying hydrophobicities from different polymer particles in aqueous environments 
as well as in living cells. We chose PLGA as the main polymer matrix because it is 
FDA-approved, widely used for a variety of biomaterials applications, and extensively 
studied as a drug carrier.
214, 219
 In the NIR region, water has vibrational absorption 
bands around 1950, 1450, 1200, and 980 nm.
220
 While the absorption coefficient 
increases at longer wavelengths, we chose 980 nm light for this study because 
wavelengths above 1100 nm were not readily available to us. However, the other 
overtone vibrational absorption bands should be capable of inducing release in a 
similar fashion. With fluorescence lifetime imaging microscopy (FLIM), we measured 
the temperature inside polymeric particles with high spatial resolution, which revealed 
increases in temperature upon irradiation at 980 nm. This simple and generalizable 
release mechanism represents a major innovation in the field of remote-controlled 
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release, as it can be applied to a large number of systems with no inherent light 
sensitivity. 
 
 
Figure 1.1. Schematic representation of NIR-induced release mechanism: (A) 
Absorption spectrum of water in the NIR region; (B) Formation of isolated nano-
domains of water in the polymeric structure; (C) Release of encapsulated molecules 
following photothermal heating of water droplets inside the polymer particles. 
 
1.3 RESULTS AND DISCUSSION 
NIR Irradiation at a Water-Resonant Wavelength Induces Payload Release from 
Polymeric Capsules  
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PLGA polymer capsules incorporating model compounds of varying 
hydrophobicities (fluorescein, Nile blue, Nile red, IR780) were produced by 
electrospray. Representative dark field images and optical epifluorescence of the 
produced dye-loaded PLGA particles are shown in Figure 1.S1 and Figure 1.S2, 
respectively. The wavelength selective response was first explored by monitoring the 
change in fluorescence intensity of a suspension of fluorescein-loaded particles (size: 
0.5 ± 0.1 µm, dye loading: ~10% w/w) before and after 15 min irradiation at 50 nm 
increments of wavelengths, ranging from 780 nm to 1030 nm (Figure 1.2A). 
Fluorescein emission increases upon release because it fluoresces more intensely in a 
polar environment, and like most organic dyes, self-quenches when its relative 
concentration exceeds ~10
-3
 M, such as when it is entrapped within particles (0.2 mol 
of fluorescein per kg of PLGA).
221
 A strong increase in fluorescence intensity was 
obtained only when the irradiation wavelength coincided with the maximum water 
absorption band, i.e., 980 nm (Figure 1.2A, open circles); profiles following 
irradiation at non-resonant wavelengths were very similar to those of non-irradiated 
control samples (Figure 1.2A, solid circles). The rate of light-induced release of 
fluorescein was also monitored by fluorescence spectroscopy (see Methods section for 
experimental details). When excited at 980 nm (1 W), the amount of released material 
rapidly increased in the first 30 min, and saturated at around 60 min (Figure 1.2B, 
open circles). The quantity of released material was found to be proportional to the 
amount of energy (number of photons) provided to the system, where a cumulative 47, 
76, and 89% of fluorescein, corresponding to 1.51 ± 0.06 µg, 2.44 ± 0.01 µg and 2.84 
± 0.05 µg, was released from the PLGA particles after 10, 30 and 60 min of 
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irradiation, respectively. Fluorescein release could be monitored visually as the 
suspension changed from colorless to bright green (Figure 1.S3A). Epifluorescence 
microscopic images (Figure 1.S3B) further confirmed NIR-triggered release: Before 
NIR irradiation, fluorescein was clearly loaded inside PLGA particles; after 
irradiation, fluorescence appeared as irregularly shaped dried patterns, rather than 
well-defined domains. In contrast, particles not exposed to light (off-state) or 
irradiated at non-resonant wavelengths (i.e., 800 nm and 900 nm) released negligible 
amounts of dye over the course of several minutes (Figure 1.2B). This wavelength 
selective response demonstrates the necessity of resonant photon interactions with 
water. The observed low background leakage of non-irradiated controls suggests that 
the fluorescein molecules remain well encapsulated inside the PLGA particles. We 
calculated a 25-fold increase in the rate of fluorescein release upon exposure to 980 
nm NIR light (on/off ratio).  
 SEM images of irradiated particles (Figure 1.S4) showed no obvious changes 
in particle morphology (i.e., size, shape, and surface texture); even after 90 minutes of 
980 nm pulsed irradiation at 1 W, no degradation was observed. To further confirm 
that 980 nm irradiation does not degrade the polymer, PLGA particles were run 
through gel permeation chromatography (GPC) before and after irradiation at 980 nm 
for 1 hr (pulsed laser, 1 W). The GPC data did not show any change in retention time 
of the polymer and/or the appearance of small molecule peaks at longer retention 
times corresponding to products of degradation (Figure 1.S5). As this mechanism 
induced release of the encapsulated payload without disruption of the polymer matrix, 
possible mechanisms such as optical cavitation or thermally-induced ester degradation 
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could be ruled out. More specifically, optical cavitation, or the formation of bubbles of 
vaporized gas in response to light, results from aqueous absorption of short laser 
pulses which generate a dielectric breakdown at the focal point, creating a plasma that 
expands and produces an acoustic shockwave.
222
 Since laser-induced cavitation 
requires intense laser light (> 200 nJ/pulse) focused at a spot size of 0.5 – 5 µm,223 and 
laser beams with pulse energy ≤ 60 nJ and spot size diameters ≥ 2 mm were used in 
this release study, it is unlikely that the observed photo-release resulted from optical 
cavitation. Although no clear evidence of particle deformation was observed by SEM, 
irradiation did appear to reduce particle stability, as reflected by collapse and 
agglomeration (Figure 1.S6). Aggregation could result from the particles being heated 
above their glass transition (Tg) and reaching a more rubbery state.
224, 225
 Nonetheless, 
the temperature increase of the bulk solution was less than a few degrees above 
ambient. We found that temperature elevations of the bulk solution from ambient 
temperature were dependent on laser power and sample volume. Irradiation at 980 nm 
(1 W, 15 min) of 0.25, 1, and 2 mL aliquots of a particle suspension resulted in 
maximum temperature elevations of approximately 10, 5, and 2 °C, respectively. In 
order to avoid unnecessary variability in the release experiments due to bulk heating, 
we can minimize temperature elevation of the bulk by working with large sample 
volumes. 
As mentioned previously, the photo-physical process involved in this release 
scheme occurs through the excitation of an overtone vibration absorption of water, and 
so, is not limited to delivery of 980 nm light as short, focused light pulses, in contrast 
to simultaneous two-photon absorption processes. Thus, efficient light-triggered 
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release can also be achieved at lower excitation powers using a more economical and 
biologically relevant continuous wave (CW) laser set-up (Figure 1.2C). By varying 
the excitation power from 170 mW to 350 mW, we found that the rate of release 
depends on the average photon energy used to excite PLGA particles. As expected, the 
release of fluorescein is faster at higher CW power, with an on/off ratio of 18 when 
irradiating at 350 mW compared to 14 and 5 when irradiating at 260 and 170 mW, 
respectively.  
Since robust control over release is desired, we assessed the activatable nature 
of this release mechanism. A permanent effect would cause continuous release after 
irradiation ends, while an activatable effect would involve slowed release profiles 
following termination of laser irradiation.
226, 227
 A fluorescein-doped PLGA particle 
suspension was irradiated repeatedly using NIR light (pulsed laser, 980 nm, 1 W) for 5 
min, followed by 15-min intervals with the laser turned off. A rapid increase in 
fluorescein release from the PLGA particles was observed upon NIR irradiation, but 
the release rate practically decreased to its initial rate when the NIR irradiation was 
switched off (Figure 1.2D). A similar on/off release ratio was observed over multiple 
consecutive exposures. This stepwise triggered release indicates that the PLGA 
particles retain their integrity upon NIR irradiation. The small payload release 
observed in the off-state may be attributed in part to water molecules diffusing into the 
space created by the loss of fluorescein from the particles, which in turn encourages 
outward diffusion.
213
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Figure 1.2. NIR-induced release occurs only at water-resonant wavelengths. (A) 
Action spectrum of the fluorescence intensity of a suspension of fluorescein-doped 
PLGA particles after 15 min irradiation (open circles) or 15 min at room temperature 
(solid circles) superimposed on the water absorption spectrum (black trace) (N = 3); 
(B) Cumulative fluorescein release after irradiation of a suspension of fluorescein-
doped PLGA particles with pulsed laser light (1 W) at 980 nm (open circles), 900 nm 
(solid pentagon), and 800 nm (open triangles). Control (no irradiation, solid squares); 
(C) Cumulative fluorescein release after irradiation of a suspension of fluorescein-
doped PLGA particles with 980 nm CW laser light at varying powers; (D) Stepwise 
triggered release from fluorescein-loaded PLGA particles using six cycles of non-
irradiation (15 min) and five cycles of irradiation (5 min, 980 nm, pulsed laser, 1 W). 
Fluorescein acquisition parameters: λex = 480 nm, λem = 520 nm. 
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Since the PLGA particles are capable of encapsulating both hydrophobic and 
hydrophilic compounds at high efficiency, the ability of this photothermal process to 
release small payloads of varying hydrophobicities was investigated. IR780, Nile red, 
and Nile blue (in order of increasing polarity) were loaded by electrospray into 
spherical PLGA capsules (~10% w/w) of 0.7 ± 0.1 µm, 1.4 ± 0.3 µm, and 1.2 ± 0.4 
µm in size, respectively (dark field microscopy: Figure 1.S1, fluorescence 
microscopy: Figure 1.S2). For all aqueous suspensions of dye-loaded PLGA particles, 
NIR exposure (980 nm, pulsed laser, 1 W) resulted in release of the dyes over time 
(Figure 1.S7). These findings revealed that this photothermal process is capable of 
sustaining release of both hydrophilic and hydrophobic compounds. A noticeable trend 
in the kinetics of release related to differences in dye polarity could be observed, i.e., 
more polar dyes were released faster. This difference could result from variations in 
water absorption: Hydrophilic content facilitates water penetration in polymeric 
carriers and leads to the creation of more porous and swelled polymer networks,
195
 
while more hydrophobic compounds hinder diffusion of water into the structure.
213, 228
 
Variations in release rate could also relate to the energy needed to induce diffusion out 
of the matrix, which should be lower for hydrophilic than hydrophobic compounds, 
since hydrophobic compounds would have higher affinity for the hydrophobic carrier. 
Also, as we have shown release with cargos that cannot be excited at 980 nm through 
two-photon absorption (Nile blue, IR780), the possibility that this light-assisted 
mechanism of  release derives from thermal relaxation of two-photon excited states 
can be discarded. 
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Role of Water in Inducing Payload Release 
In the proposed mechanism, entrapped water plays a crucial role in payload 
release by absorbing the NIR light to induce localized heating inside the particles. To 
test this hypothesis and rule out the possibility of direct absorption of optical energy 
by the polymer, we compared the release profiles of fluorescein from PLGA particles 
in deuterated water (D2O) to those in deionized water (H2O). A comparison of the 
absorption spectra of H2O and D2O shows that D2O does not absorb significantly at 
980 nm (Figure 1.3A). All of its vibrational transitions are shifted to lower energy by 
the increase in isotope mass; the vibrational band of H2O at 980 nm is shifted to 1300 
nm in D2O.
229
 Therefore, light-induced release in D2O, if observed, could only be the 
result of photonic absorption by the polymer capsules. Fluorescein-loaded particles 
suspended in D2O did not release cargo upon irradiation; the kinetic profiles matched 
those of a non-irradiated sample (Figure 1.3B). This is consistent with previous 
results showing that the laser photonic densities (≤ 1 W) used in this study do not 
result in polymer degradation (Figure 1.S5) and/or changes in PLGA particle 
morphology (Figure 1.S4), and supports the conclusion that release requires strong 
absorbance of NIR light by water (Figure 1.2). 
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Figure 1.3. Metal-free photothermal release requires efficient vibrational absorption 
by confined water. (A) Absorption spectrum of deionized (H2O) and deuterated water 
(D2O); (B) Cumulative fluorescein release after irradiation of a suspension of 
fluorescein-doped PLGA particles dispersed in H2O (solid circles) or D2O (open 
pentagons) with pulsed laser light at 980 nm. Control (no irradiation, solid squares). 
Laser power: 0.8 W. 
 
In the first stage of hydrolytic degradation, particles made of biodegradable 
polymers such as PLGA swell and take up water
213, 214
 to form domains of water in the 
hydrophobic nanostructure (Figure 1.1B).
230
 While in this state, polymers’ thermal 
behavior is affected, as the confined water acts as a plasticizer inside the polymer 
matrix by increasing the free volume of the polymer chains and consequently 
depressing the glass transition temperature (Tg); this process is called 
hydroplasticization.
231
 Using differential scanning calorimetry (DSC), we measured 
the Tg of the PLGA particles before (dry Tg) and after dispersion in water (wet Tg). 
Based on the DSC measurements, the presence of a saturated water environment 
induced a depression of the Tg of PLGA particles from 42.6 °C to 27.9 °C, thus 
confirming the presence of water inside the capsules. The measured wet Tg value was 
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in good agreement with the value predicted by a model proposed by Tsavalas et al.,
231
 
i.e., 27.1 °C, which we used to calculate a 5% water content weight fraction in the 
particles. PLGA carriers are complex 3D systems made of interconnecting pores and 
channels of different size and tortuosity distributed throughout the entire volume of 
the spheres in which water can penetrate rapidly.
232
 Pre-existing pores (in contrast to 
dynamically formed pores created upon degradation) found in PLGA particles of 
similar composition and size present diameters between 3 – 20 nm;232 water likely fills 
these pores.
233
  
Since this mechanism of release relies on excitation of confined water, it 
should work on any polyester system without inherent light sensitivity at 980 nm. This 
versatility could have significant impact because linear polyesters (e.g., PLGA, 
poly(lactic acid) and polycaprolactone) constitute one of the most important classes of 
synthetic biodegradable polymers
234, 235
 due to their biodegradability and 
biocompatibility, as well as their easily tailored physicochemical and mechanical 
properties.
236, 237
 We examined the applicability of this mechanism of release to other 
polyesters using Nile red-loaded polymer capsules (see inset in Figure 1.S9 for 
molecular structures).
238
 Fluorescence microscopy images of the resulting 
electrosprayed particles (polyester 1: 0.9 ± 0.1 µm, polyester 2: 2.3 ± 0.5 µm) can be 
found in Figure 1.S8. For both aqueous suspensions of dye-loaded particles, NIR 
exposure (980 nm, pulsed laser, 0.9 W) resulted in release of the Nile red molecules 
over time (Figure 1.S9). Both sets of particles presented similar stability in the 
absence of irradiation, suggesting that the confined water-assisted mechanism of 
release applies to multiple polyesters.
239
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Another important class of delivery vehicles are particles made from 
derivatized polysaccharides (e.g. methacrylated hyaluronic acid,
240
 chitosan,
241
 and 
modified dextran
242, 243
), which have attracted considerable attention for their tunable 
degradation rates, high processibility, and biocompatible byproducts. To study the 
applicability of this photo-physical mechanism to induce release from sugar-based 
polymers, we formulated Nile red-doped acetalated dextran particles using 
electrospray (size: 1.6 ± 0.5 µm, see Figure 1.S8 for fluorescence microscopy images 
and size distribution histogram of the resulting particles) and tested the responsiveness 
of these particles to irradiation at 980 nm (pulsed laser, 0.9 W). Similarly to polyester 
particles, non-irradiated particles showed low background leakage (Figure 1.S9C, 
solid squares), whereas irradiation at 980 nm induced a strong increase in payload 
release (Figure 1.S9C, open circles). These results support the inference that remote-
controlled photo-release using a water-resonant wavelength is applicable to a large 
number of systems with no inherent light sensitivity. 
Evaluation of the Internal Temperature of the Particles upon 980 nm Irradiation 
Fluorescent molecular thermometer represents a promising tool for intra-
particle thermometry, as it functions at the molecular level and, thus, would be 
effective in monitoring temperature within micron-sized domains. The strong effect of 
temperature on the fluorescence of molecular probes has led to various sensing 
strategies based on changes in emission wavelength and/or fluorescence intensity.
244, 
245
 In addition, excited-state lifetimes of fluorescent molecules are intensely affected 
by temperature, showing in most cases shorter lifetimes at higher temperatures.
246
 This 
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temperature dependence results from the increasing importance of non-radiative decay 
rates at higher temperatures. In this study, FLIM was used to extract intra-particle 
temperatures by comparing fluorescein lifetime to a standard curve generated by direct 
heating of the dye. This thermometric methodology allowed temperature 
measurements inside polymeric particles with high spatial and temperature resolution. 
To image individual particles for an extended period of time, particles were 
stabilized in polyacrylamide hydrogels (see Methods). We first acquired a calibration 
curve relating free fluorescein lifetime and temperature by manually heating a 
polyacrylamide gel containing fluorescein from 20 °C (room temperature) to 70 °C 
and acquiring lifetime decay curves using a Time-Correlated Single Photon Counting 
(TCSPC) system on a spectrofluorometer. The average excited- av.) 
were then extracted (see Table 1.S1) av. av. 
(X°C) – av. (20°C)) as a function of temperature (Figure 1.4A). The excited-state 
lifetime deceased with increasing temperature following a negative linear relationship 
with a calculated sensitivity of -8 picoseconds (ps)/°C. For the FLIM measurements, 
gels containing fluorescein-doped PLGA particles were placed in a reading chamber 
containing water. Single particles or small particle aggregates were irradiated at 980 
nm (pulsed laser, 10 mW) in a raster scan motion to ensure complete irradiation of the 
entire particle/aggregate. FLIM images were acquired every 5 min and an average 
lifetime was extracted from each image by integration of all pixels. Fluorescein’s 
absorption/emission wavelengths and fluorescence lifetime are relatively insensitive to 
the environment’s polarity, therefore changes in lifetime recorded for the free dye in 
the hydrogel (Figure 1.5A) should correlate well to those recorded in the particles. 
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Since fluorescein can be excited at 980 nm through two-photon absorption, the decay 
curves could be acquired while particles were continuously irradiated. Measurement of 
particle temperature via lifetime of encapsulated fluorescein would not otherwise be 
possible, as the particles’ internal temperature equilibrates with that of the surrounding 
solution rapidly after irradiation. Lifetime measurements reveal increases in the 
lifetime of fluorescein within particles following cessation of irradiation (Figure 
1.S10).  
The average lifetime of fluorescein within particles, as extracted from FLIM 
images, clearly decreases with increasing irradiation time (Figure 1.4B, open circles, 
see also Table 1.S2 for lifetime data av. = -267 ± 31 ps, tirr. = 25 min) following 
an exponential trend. According to the change in lifetime versus temperature 
calibration curve in Figure 1.4A, the average internal temperature of PLGA particles 
reached 34, 45 and 54 °C following 5, 15 and 25 min irradiation, respectively, well 
above the wet Tg of the dye-doped PLGA particles. On the other hand, the lifetime of 
free fluorescein embedded in polyacrylamide gels did not decrease upon irradiation 
(Figure 1.4B, solid circles, see also Table 1.S3 for lifetime data). This data suggests 
that the absorbed optical energy can be efficiently dissipated throughout the bulk 
hydrogel, preventing excessive localized heating. The observed selective heating of 
polymeric particles versus the bulk aqueous environment can be attributed to the 
enormous volume difference between the two; the heat capacity of water within nano-
domains is lower than that of bulk water. Also, it has been shown that water molecules 
confined in hydrophobic micro/nanostructures possess a much higher thermal 
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conductivity than bulk water.
247
 The space constraint causes an increase in collision 
frequency, which enhances energy and heat transfer.  
Example FLIM images of small aggregates of particles within irradiated 
hydrogels show the consistency of decreasing fluorescein lifetime with increasing 
irradiation at 980 nm (Figure 1.4C). Though dye-doped particles presented different 
average lifetime values before irradiation (likely due to variations in particle size and 
dye loading), the change in lifetime of each particle as a function of irradiation time 
was comparable regardless of its initial value. These images also clearly show that 
thermal changes happened exclusively inside particles; no noticeable changes in the 
surrounding hydrogel were observed. Furthermore, because of the high spatial 
resolution of the FLIM system, regions of intense changes in lifetime were discernible 
throughout the whole polymer matrix, which suggested that water-rich areas capable 
of generating substantial heat were present within the PLGA particles. Using the 
relation found in Figure 1.4A, the corresponding average internal temperature was 
added to each FLIM image. These temperature changes were more modest than in 
other thermally induced release mechanisms, especially compared to those involving 
gold nanostructures, which are reported to be well above 250 °C.
203, 204
 Compared to 
gold, for example, water has a much higher heat capacity (Cp, water = 4.186 J/g·°C; 
Cp, gold = 0.129 J/g·°C),
248
 which means that it requires more optical energy to raise 
its temperature by the same amount. Ultimately, because the Tg of most biodegradable 
polymers is below 60 °C,
249
 the resulting localized heating is enough to soften 
polymer matrices and induce release of the encapsulated payloads. An attractive 
option to increase the photon-to-heat conversion efficiency, and hence conserve the 
69 
 
 
same release efficacy at lower laser powers, would be to exploit water absorption 
bands with greater absorptivity (i.e., 1200, 1450, and 1950 nm). This could prove 
especially useful for release experiments in highly scattering environments, as the 
laser beam would quickly broaden and lose its high peak power while travelling 
through the sample. Also, the polymeric capsules’ sensitivity towards 980 nm 
excitation should be related to the amount of confined water in the polymeric capsules, 
which is greatly influenced by polymer composition (e.g. proportion of hydrophilic 
functionalities, potential to form intra-polymer hydrogen bonds, elastic modulus).
230, 
231
 Thus, studying the effect of polymer composition (e.g. introducing hydrophilic 
functionalities) on particles’ sensitivity to NIR light represents an exciting future 
direction and logical continuation of this work. 
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Figure 1.4. Fluorescence lifetime imaging (FLIM) reveals an increase in particles’ 
internal temperature. (A) Change in average lifetime (picoseconds, ps) of free 
fluorescein in a polyacrylamide gel caused by heating to various temperatures; (B) 
Changes in average lifetime of free fluorescein in a polyacrylamide gel (solid circles) 
(N = 4) or encapsulated in PLGA particles and embedded in a polyacrylamide gel 
(open circles) (N = 6) upon irradiation at 980 nm (pulsed laser, 10 mW) for varying 
periods; (C) two examples of FLIM images of fluorescein-doped PLGA particles 
embedded in a polyacrylamide gel after varying periods of irradiation at 980 nm 
(pulsed laser, 10 mW). The internal temperature was extracted from the calibration 
curve in (A).  
 
Light-activated Intracellular Release 
To examine whether this mechanism allows release of cargo from particles 
within cells, we first formulated polyester 2.1 particles (size: 0.7 ± 0.1 µm, see Figure 
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1.S11 for dark field microscopy and size distribution histogram) encapsulating the 
model release compound fluorescein diacetate (FDA). FDA is non-fluorescent in its 
native form but becomes highly fluorescent upon uptake by cells, as intracellular 
esterases hydrolyze the diacetate groups to produce fluorescein. Polyester 2.1 was 
chosen for these experiments because it possesses a glass transition in aqueous 
environments close to 37 °C (calculated wet Tg of 40 °C), which translates to less 
temperature-dependent release than PLGA (measured wet Tg of 28 °C). Particles were 
incubated with macrophages for 3 h, and cells were analyzed by flow cytometry 
following separation from free particles by centrifugation. Irradiation of cells 
incubated with FDA-loaded particles at 980 nm for 15 and 30 min resulted in 28- and 
71-fold greater cell-associated fluorescence, respectively, than cells alone, while 
fluorescence increased by only 14-fold in non-irradiated cells (Figure 1.5). Not all 
cells took up FDA-loaded particles, as indicated by the left shoulder of the curves 
representing cells incubated with particles. The increase in released FDA with 
irradiation time, as indicated by fluorescence of its cleaved product, indicates tunable 
control over the dose of cargo released. We believe that light-triggered FDA release is 
the result of heating of the confined water in the polyester particles because the 
increase in temperature of the bulk environment was minimal, from 37 ± 0.1 °C to 
38.8 ± 0.1 °C after 30 min of irradiation (980 nm, pulsed laser, 0.5 W). 
As irradiation at 980 nm could be harmful to cells, its effects on cell count and 
viability were measured. Upon exposure to 980 nm light (pulsed laser, 0.5 W, 30 min), 
no change in cell viability was observed (non-irradiated cells: 98.5 ± 0.6% viable; 
irradiated cells: 97.9 ± 0.6% viable; see Figure 1.S12A) and only a slight decrease in 
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cell density (19%) was detected (non-irradiated cells: 350 ± 10 cells/µL; irradiated 
cells: 290 ±  20 cells/µL; Figure 1.S12B), which indicates that irradiation at this laser 
power causes minimal damage to living cells. The cytoxicity of the particles 
themselves has previously been reported as minimal up to a particle concentration of 
100 µg/mL. These results demonstrate that 980 nm irradiation of polyester particles is 
a suitable means of triggering cargo release in living cells. 
 
 
Figure 1.5. NIR light-triggered intracellular FDA release. Background, cells incubated 
without particles (background); remaining traces, cells incubated with FDA-loaded 
particles and irradiated for varying periods. Irradiation: 980 nm, pulsed laser, 0.5 W. 
 
1.4 CONCLUSION 
In the present study, we have demonstrated the feasibility of exploiting the 
unusual behavior of water confined within biodegradable polymeric particles to 
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thermally induce a phase change upon NIR irradiation in polymer carriers with no 
inherent light sensitivity and achieve controlled release of an encapsulated payload in 
aqueous environment and in living cells. This metal-free photo-induced release 
strategy involves: (1) water diffusion into the polymer particles, (2) light-induced 
heating of confined water by targeting the overtone vibrational absorption band of 
water at 980 nm, (3) conductive heat transfer from the excited water droplets to the 
polymer matrix, (4) thermal phase change of the polymer particles to a more rubbery 
state, and (5) increase of the particles diffusivity and release of their encapsulated 
content. NIR light induced significant release of both hydrophilic and hydrophobic 
small molecules. The on-demand rate of release was found to depend on the average 
NIR photon energy administered to the system. Multiple consecutive NIR exposures 
can be used to obtain multiple release doses without irreversible rupture of the 
carriers, and, given the high encapsulation efficiency of the electrospraying technique, 
allows a large number of release cycles. This new release mechanism provides 
additional benefits: wavelength selectivity and high sensitivity, which allows the use 
of low CW laser power and avoids excessive heating. With more research, we foresee 
multiple applications such as light-activated self-healing capsules, extracellular 
scaffolds (nanofibers, hydrogels) providing on-demand delivery of cues for cell 
proliferation, differentiation, or migration, activatable fluorescent particles based on 
thermochromic dyes, and light-triggered drug delivery systems.
194, 207, 250
 Given the 
successful demonstration of 980 nm laser-driven in vivo diagnosis
251-253
 and 
therapy
254-256
 at depths of several millimeters without excessive heat generation or 
tissue damage, we are hopeful that NIR-induced heating of particle-confined water 
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may be widely adopted for site-specific photorelease in animal models, especially 
where light has direct access, e.g. in the eye or optically transparent organisms such as 
C. elegans or zebrafish embryos. 
1.5 METHODS 
Materials  
Poly(lactic-co-glycolic acid) (PLGA, ratio: 50:50; Mw: 7-17 kDa; alkyl ester 
terminated), polystyrene (Mw: 35 kDa), fluorescein (acid free, 95%), Nile blue 
chloride (85%), Nile red (technical grade), IR780 (98%), fluorescein diacetate (FDA), 
dextran (9-11 kDa), acrylamide (molecular biology grade), and N,N’-methylene 
bisacrylamide (99%) were purchased from Sigma Aldrich. Pluronic F127 (13 kDa) 
was purchased from O-BASF. Lithium acylphosphinate salt was synthesized 
according to a procedure published by Fairbanks et al. 
257
 Dextran was acetalated 
according to a procedure described by Suarez et al.
258
 The synthesis of polyester 1 and 
2 can be found elsewhere.
238
 Chloroform (CHCl3, 99.8%, EMD), dimethylformamide 
(DMF, 99%, Aldrich), tetrahydrofuran (THF, 99%, Fischer Scientific), and deuterated 
water (D 99.9%, Cambridge Isotope Inc.) were used without further purification. De-
ionized water (DI H2O) was purified from a Millipore system (18.2 MΩ). 
Preparation and Characterization of Polymer Particles 
The polymer capsules incorporating model release compounds were produced 
by electrospray. This formulation method employs high voltages to inject charge into a 
liquid, causing the liquid to break into a jet of fine aerosol droplets propelled towards 
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a metal plate collector. As the solvent evaporates in flight, dense, solid polymer 
particles are generated.
259
 A variety of parameters, such as applied voltage, solution 
injection rate, and plate collector height, can be tuned to control the size and 
morphology of the particles.
260
 This versatile method yields highly reproducible 
particles and entraps payloads at high encapsulation efficiencies. The dye-doped 
particles were obtained as follows: For most formulations, the polymer (100 mg) was 
dissolved in 0.75 mL of CHCl3 and diluted with a solution containing the active 
compound in DMF (40 mg/mL, 0.25 mL) at 10% w/v. The prepared solutions were 
electrosprayed at 20 kV (Gamma High Voltage, ES30) at a flow rate of 0.5 mL/hr (KD 
Scientific) using a 25 gauge needle. However, for polyester 1 particles encapsulating 
FDA molecules, 35 mg of the polymer was mixed with 3.5 mg of FDA, and dissolved 
in 0.5 mL of 3:1 DMF/THF (7% w/v). This solution was electrosprayed at 28 kV 
(Gamma High Voltage, ES30) at a flow rate of 0.1 mL/hr (KD Scientific) using a 25 
gauge needle. The duration of the spray was kept the same between samples in order 
to yield the same final electrosprayed mass of polymer. Samples were collected onto 
microscope glass slides on an aluminum plate collector at a distance of 30 cm. The 
particles (~ 2 mg) were removed from their glass slide substrate by sonication in DI 
H2O, washed with DI H2O and finally dispersed in 5 mL of DI H2O. 
The morphology of the polymer particles was examined by fluorescence 
microscopy (Nikon, Eclipse, NIS Elements software) and SEM (Agilent, 8500). 
Particle diameter distributions were extracted from recorded fluorescence images and 
SEM photographs using NIS Elements (Nikon) and ImageJ software (NIH). The 
degree of polymer degradation induced by irradiation at 980 nm was studied by gel 
76 
 
 
permeation chromatography (Waters), comparing a particle solution exposed to NIR 
light (980 nm, pulsed laser, 1 W) for one hour to an un-irradiated sample. The amount 
of dye incorporated into the various particles samples was determined by dissolving 
the particles with CHCl3 to release the dye from the particles. Fluorescein- and Nile 
blue-loaded PLGA particles (5 mL, 0.4 mg/mL) were solubilized in 0.5 mL of CHCl3 
first and then diluted in DI H2O to a volume of 50 mL, whereas Nile red- and IR780-
loaded PLGA particles were completely solubilized in 50 mL CHCl3. The 
fluorescence of the mixtures was measured and the dye concentration quantified by 
linear calibration with matrix-matched standards. Steady-state fluorescence 
measurements were performed using a Fluorolog spectrofluorimeter (Horiba Jobin-
Yvon) and quartz cuvette (volume: 1.5 mL, optical path length: 1.0 cm). Differential 
scanning calorimetry (DSC, Perkin Elmer DSC-7) was used to measure the glass 
transition temperatures of PLGA. 
Release Experiments in Aqueous Environment 
In a typical experiment, release from polymer particles was photo-initiated by 
irradiating aliquots (0.4 mg/mL) in a micro quartz cuvette at 50 nm increments from 
780 nm to 1030 nm, for specified periods of time using either a Ti:Sapphire laser (Mai 
Tai HP, Spectra Physics, 100 fs pulse width, 80 MHz repetition rate, 1 W, beam dia.: 2 
mm) or a CW laser diode (Thorlabs, 980 nm only, 170 – 350 mW, beam dia.: 2 mm). 
A wave plate/polarizer combination was used to ensure an equal output power at 980, 
900 and 800 nm. Release of the dyes was followed by fluorescence spectroscopy and 
an emission spectrum was recorded immediately after every irradiation period. The 
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release experiments regarding the hydrophilic dyes (fluorescein, Nile blue) were 
performed in pure water, whereas for the hydrophobic dyes (Nile red, IR780), a 
surfactant (pluronic F127, 0.1% w/v) was added to the particle solutions to establish a 
sink condition to facilitate release. The morphology of the irradiated particles was 
investigated by optical microscopy and SEM. Solution temperatures were measured 
using a thin wire thermocouple (J-Kem Scientific) immersed in the particle solutions 
while irradiating with the NIR light sources and connected to a temperature controller 
(J-Kem Scientific). Digital photographs were acquired using a Panasonic DMC-ZS5. 
The fraction of released material was quantified using fluorescence spectroscopy. 
Typically, after varying periods of irradiation, irradiated samples and non-irradiated 
controls were spun down (4500 rpm, 15 min) to separate the released material in the 
supernatant from the payload still encapsulated in the particles. The supernatant and 
particle pellet were dried (rotovap, vacuum) and subsequently dissolved in organic 
solvent (CHCl3 or DMF). The fluorescence spectra were acquired and the fluorescence 
intensity of the supernatant was compared to the total fluorescence intensity, i.e., 
supernatant and particle pellet, to obtain the percentage of released material. The dye 
concentration was quantified by linear calibration with standards. 
Nanoparticle Uptake and Photocontrolled Release in Cells 
MV-4-11 (ATCC® CRL-9591
TM
) human lymphoblast macrophage cells from 
peripheral blood were purchased from ATCC and cultured in Iscove’s Modified 
Eagle’s Medium (IMEM) supplemented with 10% fetal bovine serum. Cells were 
cultured in suspension and passaged three times before the experiment. Cells (5 x 10
5
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/mL) were incubated at 37 °C, 5% CO2, with FDA-loaded polyester 1 particles (100 
µg/mL) suspended in IMEM for 3 h to accomplish cellular uptake. The cells were then 
isolated by centrifugation and washed three times with IMEM to remove particles that 
were not internalized and remained free in media. To induce intracellular release and 
subsequent hydrolysis of FDA molecules, aliquots (100 µL) of cells containing FDA-
loaded particles were irradiated at 980 nm (pulsed laser, 0.5 W) for 15 and 30 min to 
maximize exposure of the sample to the laser. The sample was subsequently diluted 
eight-fold and quantified using a guava EasyCyte flow cytometer (Millipore). Non-
irradiated cells incorporating FDA-loaded particles were similarly prepared and 
analyzed as a control to probe the effect of nonspecific FDA release, whereas cells 
incubated without polymeric particles were used to set the background threshold. A 
commercial cell viability assay (Guava ViaCount, Millipore) was performed on non-
irradiated and irradiated cell suspensions (980 nm, pulsed laser, 0.5 W, 30 min), 48 
hours post irradiation to determine the effect of the laser on cells. 
Internal Temperature Measurement using Fluorescence Lifetime 
All lifetime experiments were performed on fluorescein-doped particles or free 
dye embedded in polyacrylamide gels. The hydrogels containing the particles were 
obtained by mixing a 250-µL particles aliquot (0.4 mg/mL) with acrylamide (60 mg), 
bis-acrylamide (1.4 mg) and lithium acylphosphinate salt (58 mg/mL, 10 µL). The 
gelation was photo-initiated under UV irradiation (30 s, Luzchem). To obtain the free 
dye embedded in hydrogels, 250-µL fluorescein-doped PLGA particles aliquot (0.4 
mg/mL) was first heated at 65 °C for 15 min to release the dye molecules from the 
79 
 
 
PLGA particles and the empty polymer particles were removed by centrifugation 
before applying the same gelling process. 
Fluorescence lifetime spectroscopy was done using a time-correlated single 
photon counting (TCSPC) system (Horiba) equipped with a NanoLED excitation 
source (488 nm, 1 MHz impulse repetition rate, Horiba) and a R928P detector 
(Hamamatsu Photonics, Japan). The detector was set to 520 nm for detection of 
fluorescein. The slit width varied between 2 and 20 nm to achieve an appropriate 
count rate. The instrument response function (IRF) was obtained by using a scattering 
solution of Ludox-40 (Sigma-Aldrich) in water (prompt) at 480 nm emission. The 
samples and the prompt were measured in a semi-micro quartz cuvette. The lifetime 
was recorded on a 450 ns scale. A total of 4094 channels were used with a time 
calibration of 0.110 channel/ns. All decay curves were fitted with one exponential. 
The fluorescence lifetimes were extracted using DAS6 v6.6 decay analysis software 
(Horiba). The goodness of fit was judged by χ2 values, Durbin–Watson parameters, 
and visual observation of the fit line and residuals, which should be distributed 
randomly about zero. 
Fluorescence lifetime imaging was performed on a SliceScope two-photon 
microscope (Scientifica, UK) using a 60X water immersion objective (LUMPLFLN 
60XW, NA=1.0, Olympus). A Chameleon Ultra ΙΙ IR laser (Coherent) (80 MHz 
repetition rate, 100 – 150 fs pulses) tuned at 980nm was used for the excitation of both 
fluorescein and confined water. ScanImage r3.8 was used to control the scanning 
mirrors.
261
 Fluorescence emission was detected with a hybrid PMT detector (HPM-
100-40, Becker and Hickl, Germany) between 490 – 540 nm by means of a 
80 
 
 
GFP emission filter (ET 515/50, Chroma). The acquisition of fluorescence lifetimes 
was synchronized by a TCSPC module (SPC-150, Becker and Hickl). The following 
parameters were kept constant for all acquired images: pixel size (30 nm; all 512 x 512 
pixels), pixel dwell time (3.2 µs), laser excitation intensity (10 mW after the 
microscope objective), and FLIM acquisition time (60 s/image). Fluorescence lifetime 
images were analyzed with SPCimage (Becker and Hickl). To minimize lifetime 
calculation errors, we used a minimum threshold of 15 photons at the peak 
(corresponding to ~1000 photons per pixel), and a binning factor between 2 and 10 
pixels to assure sufficient photons in the regions of interest. The same calculated IRF 
was used for all experiments. The control images of free fluorescein in polyacrylamide 
gels were analyzed with a single exponential model, whereas the PLGA particles 
images were much better fitted with a double exponential model. The goodness of fit 
was evaluated with χ2 values and visual observation of the fit line and residuals. 
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1.8 SUPPORTING INFORMATION 
SEM images, fluorescence microscopic images, particle size distributions of 
the electrosprayed particles, release profiles, cytotoxicity, and lifetime data. 
Photographs of particle suspensions before and after irradiation. Fluorescence release 
experiments. This material is available free of charge via the Internet at 
http://pubs.acs.org. 
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Supplemental Figures 
 
Figure 1.S1. Electrosprayed PLGA particles are uniform. (A) Dark field microscopic 
images and (B) size distribution histogram of fluorescein-loaded PLGA particles; (C) 
Dark field microscopic images and (D) size distribution histogram of Nile Blue-loaded 
PLGA particles; (E) Dark field microscopic images and (F) size distribution histogram 
of Nile Red-loaded PLGA particles; (G) Dark field microscopic images and (H) size 
distribution histogram of IR780-loaded PLGA particles. 
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Figure 1.S2. Electrosprayed PLGA particles efficiently encapsulate the dye 
molecules. Optical fluorescence microscopic images of (A) Fluorescein-loaded PLGA 
particles, (B) Nile Blue-loaded PLGA particles, and (C) Nile Red-loaded PLGA 
particles. 
 
 
Figure 1.S3. (A) Digital photographs of a solution of fluorescein-loaded PLGA 
particles in water after 0, 5, 10, 15, 30, and 45 min laser irradiation (980 nm, pulsed 
laser, 1 W); Fluorescence microscopy images of fluorescein-loaded PLGA 1 particles 
(B) before and (C) after laser irradiation (980 nm, pulsed laser, 1 W, 45 min). 
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Figure 1.S4. SEM images of fluorescein-loaded PLGA particles (A) before and (B) 
after 980 nm irradiation (pulsed laser, 1 W, 90 min). 
 
 
Figure 1.S5. GPC chromatograms of the PLGA before (black trace) and after 
irradiation (red trace) at 980 nm for 1 hr. (pulsed laser, 1 W). 
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Figure 1.S6. Photographs displaying laser-induced particles agglomeration over time 
(980 nm pulsed laser, 1 W). Initially, particles are well dispersed (t = 0). After 5 min 
of exposure to laser irradiation, minimal amounts of aggregates are observed. 
Agglomeration becomes significant after 10 min irradiation. Aggregates can be easily 
broken up and suspended in solution by sonication. 
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Figure 1.S7. NIR irradiation at a water-resonant wavelength induces release of both 
hydrophobic and hydrophilic compounds. (A) Cumulative Nile Blue release after 
irradiation of a suspension of Nile Blue-doped PLGA particles with pulsed laser light 
(1 W) at 980 nm (open circles). Control (no irradiation, solid circles). λex = 460 nm, 
λem = 475 – 750 nm; (B) Cumulative Nile Red release after irradiation of a suspension 
of Nile Red-doped PLGA particles with pulsed laser light (1 W) at 980 nm (open 
circles). Control (no irradiation, solid circles). λex = 560 nm, λem = 570 – 750 nm; (C) 
Cumulative IR780 release after irradiation of a suspension of IR780-doped PLGA 
particles with pulsed laser light (1 W) at 980 nm (open circles). Control (no 
irradiation, solid circles). λex = 740 nm, λem = 750 – 900 nm. [dye] = ~10% w/w. 
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Figure 1.S8. (A) Fluorescence microscopy images and (B) size distribution histogram 
of Nile Red-loaded polyester 1 particles; (C) Fluorescence microscopy images and (D) 
size distribution histogram of Nile Red-loaded polyester 2 particles; (E) Fluorescence 
microscopy images and (F) size distribution histogram of Nile Red-loaded acetalated 
dextran particles. 
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Figure 1.S9. NIR irradiation at a water-resonant wavelength can induce release from 
capsules made of different polymeric materials. Cumulative Nile Red release after 
irradiation of a suspension of Nile Red-doped (A) polyester 1 (MW = 51 kDa), (B) 
polyester 2 (MW = 17 kDa) and (C) acetalated dextran (MW = 9-11 kDa) particles 
with pulsed laser light (1 W) at 980 nm (open circles). Controls (no irradiation, solid 
circles). Molecular structures of the polymers are shown as insets on the graphs. λex = 
560 nm, λem = 570 – 750 nm. [dye]polyester 1 = ~20% w/w, [dye]polyester 2 = ~10% w/w, 
and [dye]acetalated dextran = ~10% w/w. 
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Figure 1.S10. Changes in average lifetime of fluorescein encapsulated in PLGA 
particles and embedded in a polyacrylamide gel (N = 6) upon alternating cycles of 
irradiation at 980 nm (5 min) and non-irradiation/relaxation (5 min). 
 
 
Figure 1.S11. Electrosprayed FDA-doped polyester 1 particles. (A) Dark field 
microscopic image and (B) size distribution histogram. 
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Figure 1.S12. Cytotoxicity study on the effect of NIR-irradiation: (A) Viability and 
(B) cell density with or without irradiation at 980 nm (pulsed laser, 0.5 W). Cell type: 
MV-4-11 (ATCC® CRL-9591TM) human lymphoblast macrophage cells. 
 
Supplementary Tables 
Table 1.S1. Fluorescence lifetime data for fluorescein molecules in a polyacrylamide 
gel heated at various temperatures. 
 
τav. is the averaged lifetime value and χ
2
 is the “quality of fit” parameter. ∆τav. is the 
change in lifetime and is calculated using the following equation: ∆τav. = τav. (X°C) – 
τav. (20°C). 
 
T (°C) τav. (ns) Error (ns) ∆τav. (ps) Error (ps) χ
2
20 3.680 0.005 0 5 1
30 3.605 0.004 -75 4 1.2
40 3.52 0.01 -156 13 1
50 3.44 0.02 -237 23 0.9
60 3.359 0.004 -321 4 0.8
70 3.286 0.003 -394 3 0.8
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Table 1.S2. FLIM data of fluorescein within particles embedded in a polyacrylamide 
gel after different irradiated time at 980 nm. 
 
τav. is the averaged lifetime value. ∆τav. is the change in lifetime and is calculated using 
the following equation: ∆τav. = τav. (X°C) – τav. (20°C). 
 
Table 1.S3. FLIM data of fluorescein free in a polyacrylamide gel after different 
irradiated time at 980 nm. 
 
τav. is the averaged lifetime value. ∆τav. is the change in lifetime and is calculated using 
the following equation: ∆τav. = τav. (X°C) – τav. (20°C).
 
Time (min) τav. (ps) ∆τav. (ps) τav. (ps) ∆τav. (ps) τav. (ps) ∆τav. (ps) τav. (ps) ∆τav. (ps) τav. (ps) ∆τav. (ps) Mean ∆τav. (ps) Error (ps)
0 1930 0 1888 0 1628 0 1903 0 2272 0 0 0
5 1893 -37 1655 -233 1557 -71 1756 -147 2209 -63 -110 30
10 1840 -90 1657 -231 1536 -92 1694 -209 2177 -95 -143 26
15 1688 -242 1636 -252 1527 -101 1721 -182 2052 -220 -199 22
20 1635 -295 1654 -234 1476 -152 1645 -258 2055 -217 -231 22
25 1594 -336 1563 -325 1425 -203 1683 -220 2019 -253 -267 31
Replica 1 Replica 2 Replica 3 Replica 4 Replica 5
Time (min) τav. (ps) ∆τav. (ps) τav. (ps) ∆τav. (ps) τav. (ps) ∆τav. (ps) τav. (ps) ∆τav. (ps) τav. (ps) ∆τav. (ps) Mean ∆τav. (ps) Error (ps)
0 2732 0 2724 0 2705 0 2667 0 2638 0 0 0
5 2785 53 2799 75 2602 -103 2608 -59 2640 2 -6 39
10 2785 53 2644 -80 2612 -93 2789 122 2537 -101 -20 47
15 2791 59 2624 -100 2613 -92 2906 239 2531 -107 0 71
20 2836 104 2688 -36 2602 -103 2963 296 2594 -44 43 79
25 2823 91 2674 -50 2583 -122 2982 315 2577 -61 35 86
Replica 1 Replica 2 Replica 3 Replica 4 Replica 5
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Chapter II: 
 
Selective Photothermolysis Theory and Gold-Nanoparticle Laser-Induced 
Photothermal-Assisted Liposuction (Nanolipo) in a Porcine Model 
 
2.0 CHAPTER TWO PREAMBLE 
In the Introductory Chapter, I presented an overview of the field of 
photothermal therapy and argued that, in order to practically apply the photothermal 
effect in biological systems, the focus should not be the development of more 
photothermal agents, but rather the confinement of heat to specific targets of interest. 
The work presented in Chapter I was valuable in exposing me to how selective heat 
confinement might be achieved, but also in helping me realize the limitations of using 
wavelengths of light outside of the biological optical window. In this chapter, I 
explore this concept further and present a detailed derivation of the fundamental 
principles underlying selective photothermolysis, citing seminal works in the field by 
R.R. Anderson, John A. Parrish, and later, G.B. Altshuler. I also present my own work 
in developing a bulk-scale proof-of-concept selective photothermolysis model using a 
thermoresponsive polymer, which undergoes a change in opacity after being heated 
through its lower critical solution temperature (LCST), as an indicator for selective 
photothermal heating. Working with one of the most widely studied photothermal 
agents, I went on to explore the feasibility and demonstrate proof of concept for a 
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gold-nanoparticle laser-induced photothermal-assisted liposuction technology in a 
porcine model, as well as investigate the biosafety, biodistribution, and clearance of 
the gold nanoparticles from the bodies of the animals tested.  
2.1 ENGINEERING ANALYSIS OF SELECTIVE PHOTOTHERMOLYSIS 
AND MODELING 
The concept of selective photothermolysis, originally described by Anderson 
and Parrish, was briefly introduced in the Introductory Chapter. In essence, it is a 
corollary of the photothermal effect in which the parameters of light exposure are 
carefully controlled to achieve specific and targeted heating in pigmented biological 
structures within tissue. In this section, an engineering analysis of selective 
photothermolysis is briefly presented. 
The Heat Equation 
As the photothermal effect deals with the conversion of light to heat, the 
fundamental equation governing it is the heat equation. This famous partial differential 
equation (PDE) has been extremely well-studied and its derivation can be readily 
found in many engineering textbooks, since its application is quite broad. In short, the 
heat equation takes the form: 
𝜌𝐶𝑝
𝛿𝑇
𝛿𝑡
− κ∇2𝑇 = 𝐻 
Where, ρ is the mass density, Cp is the specific heat, κ is the thermal conductivity and 
H is the heat flux. This equation is commonly rearranged into the form: 
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𝛿𝑇
𝛿𝑡
− 𝐷∇2𝑇 =
𝐻
𝜌𝐶𝑝
 
Where D = κ/ 𝜌𝐶𝑝 is a term called the thermal diffusivity. 
This equation basically says that as long as there is a heat flux, H, into the 
system, there will be a rise in the temperature over time in an arbitrarily defined 
volume of tissue, which makes sense. Although the heat equation can be solved using 
numerical methods for general cases, there are simpler, more fundamental solutions in 
the form of Green’s functions. For example, the solution for a point source heat flux 
with an infinitesimally short duration in an infinite, three dimensional piece of 
homogenous tissue is: 
𝑇(𝑥, 𝑡) =  
𝐸
𝜌𝐶𝑝
(
1
8(𝜋𝐷𝑡)3/2
) exp (−
|𝑥|2
4𝐷𝑡
) 
Where E is the amount of optical energy deposited into the tissue at the point source. 
Obviously, many assumptions have to be made in order to for this solution to hold, 
and although this solution does not quite describe real-world phenomenon, it is a good 
place to start in terms of modeling thermal conduction behavior in tissue.  
By implementing different boundary conditions, such as a heat source with one 
dimensional plane geometry, applied to a three dimensional block of homogenous 
tissue, the solution then becomes: 
𝑇(𝑥, 𝑡) =  
𝐸
𝜌𝐶𝑝
(
1
2√𝜋𝐷𝑡
) exp (−
𝑧2
4𝐷𝑡
) 
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Where z is the penetration depth. Although this solution still relies on several major 
assumptions, it is much more representative of the geometry in photothermal 
applications. 
Heat Deposition from a Light Source 
In the traditional sense, heat is transferred to tissue through conduction. In the 
heating source with a plane geometry, one might imagine a hot plate placed over the 
surface of the tissue to transfer heat through the established contact surface. However, 
in photothermal applications, electromagnetic energy in the form of photons must first 
be absorbed, and then relax vibrationally to generate heat. For a continuous-wave light 
source, the thermal energy is deposited in the form of: 
𝐻 =  𝜇𝑎𝛷 
Where 𝜇𝑎 is the absorption coefficient and 𝛷 is the light fluence rate, also known as 
irradiance. In this form of photothermal heating, when the laser is turned on, the light 
is assumed to arrive at the tissue surface instantaneously. Subsequently, for as long as 
the laser is kept on, the energy will be continuously deposited into tissue and 
converted into heat through tissue vibrational relaxation or thermal relaxation.  
In contrast to laser light of a continuous-wave nature, a pulsed laser could be 
used instead. In the current context, the term “pulsed” is used to loosely describe light 
that is applied in a discontinuous manner, including continuous-wave light that is 
applied in a gated manner. The main difference between a continuous-wave and 
pulsed laser is the manner in which the energy is deposited. In the case of the 
continuous-wave laser, the parameter that is most relevant is the amount of energy 
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deposited per unit of time, since the longer the laser is kept on, the more energy is 
deposited. In the case of a pulsed laser, however, the parameter that is most relevant 
becomes the energy deposited per pulse, since the laser is not left on indefinitely. The 
thermal energy deposited can now be expressed as: 
𝐻(𝑥, 𝑡) =  𝜇𝑎(𝑥)𝛷(𝑥)𝑓(𝑡) 
Where 𝑓(𝑡) is a dimensionless parameter that describes the temporal shape of the 
pulse. By integrating the heat flux with respect to the time, the total energy deposited 
can be calculated: 
𝐸 =  𝜇𝑎(𝑥)𝛷(𝑥) ∫ 𝑓(𝑡)
∞
0
𝑑𝑡 
If the laser pulse has some duration tp, and it is assumed that energy deposition is 
instantaneously achieved and maintained for the duration of the pulse, then the energy 
deposited by each pulse is 𝐸 =  𝜇𝑎(𝑥)𝛷(𝑥)𝑡𝑝.  
Another name for the heat flux is the power density. One caveat is that the 
power density should be low enough as to not induce cavitation effects as a result of 
heating water above its boiling point, especially for applications involving 
discontinuous energy exposure.   
Heat Diffusion and Penetration Depth of Heat 
Following conversion from the absorbed light energy, heat will diffuse into the 
tissue. The two primary factors influencing heat dissipation in tissue are the heat 
capacity and thermal conductivity. Although these terms are not constant, they are 
103 
 
 
often treated as such since complex biological tissue is comprised mostly of water. By 
doing so, the thermal diffusivity in biological tissue, and thus, the thermal penetration 
depth can be estimated. The thermal penetration depth is expressed as:  
𝑧 =  √4𝐷𝑡 
Where z = 0 is defined as the surface of the tissue. By making the appropriate 
estimations, the thermal diffusivity in tissue is calculated to be approximated to be 20 
µm/ms. This value is important in determining the thermal relaxation time in tissues. 
Thermal Relaxation Time of Tissue and Selective Photothermolysis  
The thermal relaxation time (TRT or τ) is defined as the time it takes for the 
temperature at depth z to reach 1/e of the temperature at z = 0, where the heat source is 
located. Ultimately, it is an indicator for how fast heat is lost in an object. As it was 
explained briefly in the Introductory Chapter, and as the reader might envisage, if 
subsequent pulses of light are used to photothermally heat the target structure before it 
has time to lose its heat (t < TRT), the target structure will be heated up continuously 
and selectively compared to the surrounding areas since energy is deposited and built-
up in the target structure before diffusion can happen. This concept is in essence, 
selective photothermolysis. In the original work by Anderson and Parrish, one might 
expect a heating profile such as the one shown in Fig. 2.1.1. A prerequisite, however, 
was that the target structure had to have an absorption coefficient at least twice as high 
as that of the surrounding tissue. Since the major component in tissue is water, it 
would be difficult to achieve selective photothermolysis relying on water as the 
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absorbing pigment. Additionally, they must be spaced sparsely enough such that their 
heat diffusional areas do not overlap, as indicated qualitatively in Fig. 2.1.1. 
 
 
Figure 2.1.1. Schematic showing various achievable temperature profiles during 
selective photothermolysis. Pigmented target structures with sufficient spacing can be 
heated selectively if pulses of light are applied sequentially such that the time between 
pulses is less than the thermal relaxation rate of the absorbing structure. From 
Anderson, RR and Parrish, JA, “Selective photothermolysis: precise microsurgery by 
selective absorption of pulsed radiation.” Science, 1983. Re-printed with permission 
from AAAS. 
 
Extended theory of Selective Photothermolysis  
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Although this initial model was adequate in describing the selective 
photothermal phenomenon for the heating of specific pigmented structures, it did not 
do a good job of accounting for conduction to surrounding tissue, because after all, 
over time heat will diffuse into the surrounding tissues. Working with Anderson, G.B. 
Altshuler proposed an alternate, extended theory of selective photothermolysis that 
adds a buffer zone into consideration, physically represented as interstitial spacing 
between adjacent target structures, in calculating the extent of the selective 
photothermal effect. In essence, this allowed for more accurate calculations of the 
selective photothermal effect. The governing equations for the TRT, as well as the 
thermal damage time, input power density, and input energy fluence were all 
calculated by Altshuler for planar, cylindrical, and spherical geometries with the 
dimensional parameter d (Tab. 2.1.1,). There is actually a mistake for the “TRT of the 
heater” set of terms, where all of the d1 terms in the numerator should be squared. 
 
Table. 2.1.1. Calculation of Parameters for Achieving Selective Photothermolysis. 
From Altushuler, G.B. et al., “Extended Theory of Selective Photothermolysis.” 
Lasers in Surgery and Medicine. 2001. Re-printed with permission from Wiley. 
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Based on these equations, the necessary powers and exposure times can be estimated 
for the selective photothermolysis of target structures with specific geometries. As 
mentioned previously, these fundamental principles have been successfully applied for 
the treatment of port-wine stains, as well as for laser hair removal.  
pNIPAM Selective Photothermolysis Model 
With these fundamental principles in mind, I developed a bulk-scale model in 
order to visualize the selective photothermolysis. Poly N-isopropylacrylamide 
(pNIPAM) is a thermoresponsive polymer that undergoes a hydrophobicity change 
upon heating through its lower critical solution temperature (LCST), changing from 
hydrophilic to hydrophobic as it is heated from below its LCST to above, respectively. 
To model hypothetical selective photothermal heating in tissue, I designed a density 
gradient pNIPAM model consisting of three layers of pNIPAM solution. At the 
bottom was 5 wt% pNIPAM mixed with 10 wt % sucrose in deionized water to allow 
this layer to remain situated at the bottom. The middle, target layer consisted of 5 wt% 
pNIPAM mixed with a neodymium-based photothermal agent that I developed in the 
lab, at a concentration of 1 OD. On the top was simply a 5 wt% pNIPAM solution.  
pNIPAM in its native state (without modifications or substitutions) has a LCST of 
about 32 °C. When the density gradient solution is placed in a 50 °C water-bath as 
control, the whole solution becomes opaque, indicating that the 5 wt% pNIPAM in all 
of the layers undergo a transition simultaneously (data not shown). When a 
continuous-wave laser at 1 W/cm
2 
is used to illuminate the density gradient solution 
from above, as might be the case in heating of tissues, a small opaque region begins to 
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form in the center of the middle layer containing the PT agent, which begins to expand 
and grow. As it grows, it does not seem to be inhibited by the boundaries of the 
different layers, except maybe slightly at the middle-to-bottom layer interface. As the 
exposure time is continued, the whole solution eventually turns opaque (Fig. 2.1.2).  
 
 
Figure. 2.1.2. Continuous light exposure induces heating of the photothermal layer. 
As exposure is continued, heat expands into none-photothermally absorbing layers 
(above and below) until pNIPAM in the whole volume undergoes a LCST transition, 
turning cloudy. 
 
In contrast to the continuous wave heating, when light was applied in a 
discontinuous manner, specifically using higher power densities applied as shorter 
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pulses, the change in opacity, indicative of photothermal heating, was selectively 
restricted to the middle layer, even as the number of pulses increased (Fig. 2.1.3). 
 
 
Figure. 2.1.3. Discontinuous light exposure with sufficient cool-down times in 
between exposure events enables selective photothermal heating of only the middle 
layer of the density gradient pNIPAm solution. 
 
This model shows that it is very much feasible to confine heating to a target 
region in a selective manner by applying the principles of selective photothermolysis. 
Armed with this knowledge, we proceeded to test this concept in an animal tissue 
model. We proceeded carefully, since we know that getting light through biological 
tissue is wholly different from passing it through water, which is achieved quite 
readily in the pNIPAM model. The next section of this chapter, is in part, a reprint of 
the material as it appears in Plastic and Reconstructive Surgery - Global Open. 
Wangzhong Sheng, Ali H. Alhasan, Gabriella DiBernardo, Khalid M. Almutairi, J. 
Peter Rubin, Barry E. DiBernardo, Adah PhD Almutairi. LLW Journals 2015. The 
dissertation author was the primary investigator and author of this work. 
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2.2 ABSTRACT 
Background: Conventional suction-assisted lipectomy (SAL) often results in contour 
irregularity. Selective photothermal heating of adipose tissue by polymer-coated gold 
nanorods (AuNRs) energized by an external near-infrared (NIR) exposure at 800 nm is 
introduced in this work to facilitate fat removal. Materials and methods: The effects 
of NanoLipo were examined in food grade porcine abdominal tissue (skin, fat, and 
fascia) by histology. The efficacy of NanoLipo was compared to that of conventional 
SAL in vivo in Yucatan mini pigs by quantification of removed subcutaneous tissue 
and fatty acids and ultrasound measurement of adipose layer thickness. Results: 
NanoLipo led to the appearance of disruptions in adipose tissue that were not apparent 
in control groups in ex vivo samples. NanoLipo allowed removal of more 
subcutaneous tissue (~33% vs. ~25% of removed material, p < 0.05) and 
approximately twice as much free fatty acids (~60% vs. ~30% of removed tissue, p < 
0.05) than conventional SAL. Most importantly, NanoLipo led to a greater decrease in 
adipose layer thickness at one month post-surgery (p < 0.001). Conclusions: 
NanoLipo facilitates removal of a greater quantity of fat and requires less suction time 
(4 min vs. 10 min) than conventional SAL. As the safety of PEG-coated AuNRs is 
well-established, a clinical trial is currently being organized. 
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2.3 INTRODUCTION 
According to the most recent statistics by the American Society for Aesthetic 
Plastic Surgery, liposuction, including conventional suction-assisted lipectomy (SAL), 
ultrasound-assisted liposuction (UAL), and laser-assisted liposuction (LAL), is the 
most common aesthetic procedure performed by plastic surgeons in the United 
States.(1) However, these procedures are often associated with secondary 
complications due to irregular fat removal such as contour deformities, irregular 
lumpy appearance, and excess skin, leading to patient dissatisfaction.(2-4) In this 
article, a surgical device technology termed NanoLipo is introduced. This technology 
employs a gold nanorod (AuNR) solution energized by external near-infrared (NIR) 
laser exposure (Fig. 2.2.1) to overcome these challenges by uniformly and selectively 
heating adipose tissue while sparing surrounding tissue.   
NanoLipo heats adipose tissue by surface plasmon resonance (SPR), through 
which AuNRs absorb laser energy of specific wavelengths in the near infra-red (NIR) 
region.(5) The wavelength absorbed can be tuned by altering particle shape, size, 
geometry, and aspect ratio.(6) This absorption causes gold electrons to oscillate with 
the frequency of the electromagnetic field, generating heat with extremely high 
efficiency.(7) Photothermal conversion through SPR takes advantage of the difference 
in thermal relaxation rates between fat and surrounding tissues to allow very rapid, 
localized heating of adipose tissue.(8, 9) Because fat has a lower specific heat capacity 
(2.3 kJ g
-1 
K
-1 
for fat vs. 4.18 kJ g
-1 
K
-1
 for water),(10, 11) as well as a lower thermal 
conductivity (0.23 W m
-1
 K
-1
 for fat vs. 0.631 W m
-1
 K
-1
 for water) than water, it heats 
faster and dissipates heat slower. Heating by this mechanism selectively softens and 
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loosens adipose tissue, facilitating removal with minimal trauma. Only surgeon-
defined regions, where the AuNR solution is infused, absorb laser energy, minimizing 
the potential for damage to surrounding tissues.  
NanoLipo employs gold nanorods that absorb a wavelength within the tissue 
transparency window (800-900 nm), where competing endogenous chromophores 
including water and hemoglobin have lower absorption.(9) Current FDA-approved 
technologies for LAL rely predominantly on wavelengths around or beyond 1000 nm, 
where water absorbs and emits heat.(12) Consequently, these methods require the 
insertion of laser probes into the subcutaneous tissue to liquefy small volumes of 
fat.(13) The point source nature of the heating device makes uniform results difficult 
to achieve. Surrounding subcutaneous tissue, such as muscle and fibrous connective 
tissues, will also be heated significantly.(14, 15)  In NanoLipo, an externally applied 
benign laser source could provide more uniform planar heating than an internally 
inserted fiber optic laser, as well as increase the safety margin by selective heating of 
adipose tissue. Finally, an important advantage of the NanoLipo system is the ability 
to precisely control temperature increases through the concentration of the exogenous 
solution (Fig. 2.2.2), in addition to laser energy, pulsing sequence, and wavelength.(7) 
The amount of heating can thus be finely tuned to achieve the target temperature, 
while keeping the skin surface temperature lower than 42 °C to mechanically weaken 
adipose tissue without damage to skin.(13)  
2.4 MATERIALS & METHODS 
Gold nanorod (AuNR) solution 
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AuNR solution was produced, packaged and released in accordance with the 
FDA’s current Good Manufacturing Practice guidelines by NanoSpectra BioSciences, 
Inc. (Houston, TX) following the literature.(16) AuNRs (10 nm x 40 nm) were 
functionalized with poly(ethylene-glycol) (PEG) (5 kDa) via displacement of 
hexadecylcetyltrimethylammonium bromide (CTAB), a detergent used in the synthesis 
of AuNRs. Proposed specifications for AuNRs in the commercially produced 
NanoLipo system are summarized in Table 2.2.1. 
Laser source 
The Lumenis LightSheer® Duet
TM
 laser system (Lumenis, Yokneam, Israel), a 
commercially available, FDA-approved device with an 800 nm pulsed diode, was used 
for all studies. The laser probe, whose application area is 3.5 cm x 2.2 cm, was set to 
generate three consecutive 30 ms pulses of 6 J/cm
2
 (46 J/ pulse) each pass (i.e. 138 J 
per pass before accounting for any attenuation by the tissue). In animal studies, the 
skin was cooled using a damp towel to keep skin surface temperatures below 42 °C.  
Ex vivo studies 
Ex vivo studies were performed on food-grade porcine abdominal tissue (pork 
belly). AuNR or saline solution was injected into the experimental and control areas, 
respectively. Another region was treated with the laser only. The experimental and 
laser-only regions were exposed to 20 passes of the Lumenis laser.  Frozen sections 
(10 µm) were stained with hematoxylin and eosin, (8) prior to imaging using a 
Hamamatsu NanoZoomer 2.0HT slide scanning microscope. 
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Animal studies 
All animal studies were approved by the University of California, San Diego 
(UCSD) Institutional Animal Care and Use Committee (IACUC). Yucatan mini pigs 
(45-55 kg) were purchased from S&S Farms, Ramona, CA, housed at the UCSD pig 
facility at Elliot Farms and fed a standard diet (three meals per day). Zucker rats were 
purchased from Harlan Sprague Dawley, housed in the UCSD vivarium, and fed an 
unrestricted normal diet to maximize body fat content.  
NanoLipo procedure 
Abdominal hair was trimmed using clippers and removed using Nair
TM
. 
Following sterilization with surgical betadine, two regions were tattooed for 
conventional SAL or NanoLipo (Fig. 2.2.S1).  During all procedures, surface skin 
temperature was monitored by a FLIR E50 infrared thermal camera.  
NanoLipo solution was mixed with anesthetic tumescent solution (Ringer’s 
solution saline with 0.1% lidocaine, 1 ppm epinephrine) to a concentration of 2.5 × 
10
11
 AuNR/mL (14 μg AuNR/mL). 100 mL of the solution was injected into adipose 
tissue through a small stab incision in a systematic fan pattern to ensure uniform 
permeation and distribution in the target region (5 cm x 5 cm). The laser was applied 
to the marked area over the course of 5 ± 1 min  to deliver 1000-2000 J of energy over 
multiple passes, alternating the orientation of the laser application probe to ensure 
complete coverage of the area. The skin was cooled using a wet towel every four 
passes to maintain a safe skin temperature, as verified by the thermal imaging camera 
(FLIR E50, FLIR, Wilsonville, OR). Subcutaneous tissue was removed by suction-
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assisted liposuction (Gomco OptiVac
® 
G180, Allied Healthcare Products, St. Louis, 
MO) and the incision was closed using an absorbable suture, while the operated areas 
were marked with a non-absorbable suture. 
Processing of removed subcutaneous tissue  
Lipoaspirates were centrifuged at 1000 rpm for 5 min to separate the liquid 
phase, including injection solution, from solid subcutaneous tissue. Both phases were 
weighed, and subcutaneous tissue was examined under dark field microscopy at 10X 
magnification. Cell diameters (along the longest axis, all cells in each field of three 
representative images, totaling ~50 cells) were measured using ImageJ software. To 
quantify the proportion of removed subcutaneous tissue consisting of free fatty acids 
and glycerol, 1 g of each subcutaneous tissue sample was digested with 3 mg 
collagenase/dispase following manufacturer protocol for 1 h at 37 °C (Roche) and 
centrifuged (2000 rpm, 5 min) to produce three distinct layers (from top to bottom: 
free fatty acids and glycerol, adipocytes, and fibrous matter). The percentage of 
removed tissue consisting of free fatty acids and glycerol was determined by 
measuring the volume of the upper layer containing secreted fatty acids and glycerol, 
converting it to mass (assuming 1 mL = 1 g), and dividing by the total mass of 
removed tissue.(17)  
Ultrasound and skin appearance assessment 
Ultrasound measurements were taken using a Biosound MyLab30Vet machine 
with a LA435 Linear Probe 18-10 MHz transducer through a thick layer of ultrasound 
gel before, immediately after, and at 10 d, one month, two months, and three months 
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post-procedure to monitor changes in tissue depth. The effect of user pressure was 
accounted for by applying maximum pressure and slowly relaxing, acquiring the 
measurement the moment just before the transducer detached from the surface. 
Additionally, images were consistently acquired during exhalation to account for any 
changes in depth due to breathing. Images parallel and perpendicular to the spinal axis 
of the animal were acquired to obtain complete coverage of the operated area. The 
machine was set to measure the same depth for each region across all time points.  
In each image, the distance from the top of the deep fascial membrane to the 
top of the superficial fascial membrane, which appears white on ultrasound,(18) was 
measured at four cross-sections spaced 1 cm apart in each ultrasound image (five 
images per treated region) using ImageJ. Images in which resolution was too low to 
identify fascial membranes (fewer than 10% of images) were not analyzed. Each 
measured distance is plotted to illustrate the change in average depth over time. 
Interpretation of ultrasound was aided by compression testing during image collection; 
fat layers compressed more than fibrous layers. 
Statistics 
Continuous variables, except for adipose thickness measured by ultrasound, are 
reported as means and standard errors. Groups were compared by two-tailed student’s 
t-test in Microsoft Excel 2010. 
2.5 RESULTS 
Ex vivo fat liquefaction  
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In the first proof-of-concept experiments, food-grade porcine fatty abdominal 
tissue was used to determine the minimum concentration of NanoLipo AuNR solution 
to facilitate removal of the adipose layer at a safe laser power and short duration with 
minimal heating. Porcine tissue was subcutaneously injected with NanoLipo AuNR 
solution (0.1 g/L) and irradiated with a laser (800 nm, 2.5 kJ total, 30 ms/pulse), 
injected with AuNR solution only, irradiated without AuNRs, or left untreated as a 
control. In the absence of AuNR solution, histology showed no signs of significant 
lipolysis (Fig. 3 A, C).  Skin surface temperature was monitored and did not exceed 45 
°C in NanoLipo treated samples. NanoLipo-treated regions appeared more translucent 
than regions treated with laser alone, suggesting liquefaction of fat (Fig. S2). The 
tissue was also mechanically softer when probed with tweezers. Histology revealed 
disruption, apparent as voids, in subcutaneous adipose tissue but not in the dermal 
layer or connective tissue (superficial to the adipose layer) of NanoLipo-treated 
samples (Fig. 3 B, D). Disruption of adipose tissue in these samples made them 
noticeably more fragile and difficult to section. While deep connective tissue appears 
to be disrupted by NanoLipo, insertion of the cannula might also cause such effects.   
NanoLipo
 
efficacy in Yucatan mini pigs 
We next examined whether NanoLipo enhances fat removal relative to 
standard liposuction techniques using Yucatan mini pigs. NanoLipo and conventional 
SAL were performed on two abdominal regions on each pig. NanoLipo allowed 
removal of considerably more subcutaneous tissue (Fig. 2.2.4A) and fat than 
conventional SAL in a comparable amount of time. The NanoLipo method required 
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far less time (4 min vs. 10 min) to remove a similar volume of lipoaspirate and caused 
less bruising than SAL. Collagenase digestion and centrifugation revealed that the 
fatty content of tissue removed following NanoLipo was nearly twice that following 
SAL (Fig. 2.2.4B). Dark field microscopy of adipocytes in the lipoaspirate following 
NanoLipo showed that the adipocytes from NanoLipo-treated areas were significantly 
smaller than those from SAL-treated areas (Fig. 2.2.4C, D).  
Assessment of tissue depth using ultrasound 
The thickness of the adipose layer before and immediately after the procedure, 
as well as at 1, 2, and 3 months post-operation was measured using ultrasound (Fig. 
2.2.5). Analysis of ultrasound images reveals comparable depth changes between 
NanoLipo
 
and SAL immediately post-operation (Fig. 2.2.5C). However, the change in 
adipose tissue layer thickness at one month post-surgery is significant in NanoLipo-
treated areas (p < 0.001) but not in those treated using SAL. Similarly, reductions in 
adipose tissue layer thickness at 3 months post-surgery were greater in NanoLipo-
treated than SAL-treated areas (Fig. 2.2.5A, B).  
2.6 DISCUSSION 
Surface plasmon resonance (SPR) in metal nanostructures has been used 
extensively for photothermal therapy of cancer.(19)
,
(20) In NanoLipo, we sought to 
apply SPR-based heating to improve on conventional SAL by expanding on the 
principle of selective photothermolysis.(9) Selecting an appropriate laser pulse length, 
among other parameters, allows NanoLipo to precisely increase the amount of energy 
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conferred to the target, i.e., adipose tissue. The major advantage of this technology is a 
consequence of the addition of exogenous energy absorbers (AuNRs) rather than 
relying on endogenous elements, such as water.  
In this work, ultrasound was used to assess whether NanoLipo enhances 
reductions in adipose tissue thickness and yields more uniform results relative to 
conventional SAL. A comparison of depth changes between NanoLipo
 
and SAL 
groups immediately post-operation correlated well with the total volume of 
subcutaneous tissue removed (Fig. 4A). Ultrasound results at one month post-op 
suggests that NanoLipo’s localized thermally-aided fat removal resulted in less 
swelling or that such swelling subsides faster (Fig. 5C). NanoLipo appears to lead to 
greater reductions in thickness at 3 months post-surgery. Tissue depth reduction 
appears to be more uniform in NanoLipo-treated regions than in those treated with 
SAL across all time points, as evidenced by a tighter distribution of thicknesses (Fig. 
5C).   
The results presented herein strongly suggest that NanoLipo may aid in 
removal of adipose tissue while maintaining the integrity of overlying tissues. 
Although the NanoLipo system includes one more step than SAL, the amount of time 
saved during lipoaspiration (4 min vs 10 min to obtain the same volume) more than 
makes up for the time spent to apply the laser. This accelerated fat removal may result 
from release of fatty acids and glycerol from adipocytes, evidenced by reductions in 
the diameter of cells from lipoaspirate following NanoLipo procedures. 
The NanoLipo technique has a high safety margin. PEG-coated AuNRs have 
been studied extensively and are essentially innocuous.(21, 22) The injected dose is 
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also well below the LD50 of AuNRs (23). Furthermore, since AuNRs do not bind to 
tissue, a large portion of injected AuNRs are immediately removed by aspiration, and 
since the concentrations delivered (0.01-0.05 g/kg body weight) are well below the 
expected toxicity limit (3.2 g/kg) for gold,(23) long-term AuNR exposure is not 
expected. A long-term investigation of the distribution of AuNRs in pigs is underway. 
We anticipate the NanoLipo procedure to be well-tolerated, as the mechanical changes 
induced by selective photothermolysis are temporary.  
NanoLipo would not be significantly more expensive than conventional 
liposuction. Compatible laser systems, including the Lumenis LightSheer employed in 
this study, are widely available in cosmetic surgery clinics, and AuNRs at the 
concentration used here cost less than a dollar per liter of lipoaspirate.  
2.7 CONCLUSIONS 
In the present work, we introduce a new system, termed NanoLipo, that 
facilitates removal of a greater quantity of fat (double) and requires less time (4 min 
vs. 10 min) than conventional SAL. NanoLipo appeared to yield more uniform 
reductions in adipose layer thickness. A greater proportion of removed tissue consisted 
of fatty acids, which agrees with our hypothesis that NanoLipo causes fat liquefaction. 
The presented data suggest that NanoLipo
 
offers potential advantages over 
conventional SAL, warranting longer-term studies. 
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2.10 FIGURE LEGENDS AND TABLES 
Figure 2.2.1. Schematic of NanoLipo procedure.   A solution of NanoLipo AuNRs is 
A. infused into the adipose tissue and B. permeates it. C. An external 800 nm laser is 
applied to the epidermis; the epidermis temperature is carefully controlled by contact 
cooling (not shown). D. Adipose tissue loses its mechanical integrity as triglycerides 
stored in adipocytes are secreted as free fatty acids and glycerol. E. Adipose tissue and 
the NanoLipo solution are removed using standard liposuction procedures. 
 
Table 2.2.1. Device specifications for NanoLipo solution 
Test Procedure Specifications 
Absorption peak UV/vis spectrophotometry 800 ± 10 nm 
Particle 
concentration 
Transmission electron microscopy 
(TEM) 
1.6 x 10^13 NR/ml 
Optical density at 
800 nm 
UV/vis spectrophotometry 50 ± 5 OD 
Dimensions Transmission electron microscopy 
(TEM) 
Length : 40 ± 5 nm 
Width : 10 ± 2 nm 
CTAB 
concentration 
ISO 2871-2: determination of 
cationic-active matter content 
≤ 4 µM 
 
A B C
  
D E 
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Figure 2.2.2.  Tunable absorption of AuNR solution used in NanoLipo, which absorbs 
efficiently in the 800 nm region. Water and other endogenous chromophores do not 
absorb at this wavelength. 
 
 
Figure 2.2.3. Histological effects of NanoLipo in ex vivo porcine skin and 
subcutaneous tissue. A. H&E stained section of AuNR-injected (left) and untreated 
(right) samples and B. H&E stained section of NanoLipo-treated (left) and laser-
treated samples. C-D. Higher magnification power image of C. untreated region and 
D. NanoLipo-treated region; arrows indicate intact connective tissue and * indicates 
disruptions. Scale bars = 2.5 mm (A-B), 250 µm (C-D). 
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Figure 2.2.4. NanoLipo allows removal of more tissue and more fat than standard 
suction-assisted lipectomy (SAL). A. Subcutaneous tissue was weighed upon removal. 
B. Free fatty acids and glycerol were separated from subcutaneous tissue by digestion 
and centrifugation. C. Dark field microscopy and D. quantification of average 
diameter of adipocytes in lipoaspirates. Scale bar = 100 µM. *, p < 0.05; ***, p < 
0.001. n = 3 procedures in 3 pigs. 
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Figure 2.2.5. Ultrasound imaging analysis reveals that NanoLipo enhances 
reductions in tissue thickness. Representative ultrasound images prior to and 3 
months post-surgery of A. NanoLipo treated region and B. SAL-treated region. Red 
lines indicate adipose layer targeted by liposuction. C. Quantification of tissue 
thickness for NanoLipo (left) and SAL (right). **, p < 0.01; ***, p < 0.001 relative to 
baseline. n = 3 procedures in 3 pigs; 20 measurements per procedure. 
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Figure 2.2.S1. Treatment regions were marked with non-absorbable sutures.  
        
 
Figure 2.2.S2. Details of ex vivo experiments. Top and right, photograph of skin and 
subcutaneous fat following injection of AuNRs and laser exposure. Below, 
temperature measurement by thermal camera immediately following laser exposure of 
AuNR-injected area.   
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2.11 BIODISTRIBUTION AND CLEARANCE OF GOLD 
NANOPARTICLES FROM PIGS 
Study Background and Design 
A biodistribution and clearance study was conducted in pigs to evaluate the 
safety and efficacy of these nanomaterials in living organisms. Relative to 
photothermal therapy of cancer, the amount of material used for NanoLipo is nearly 
two orders of magnitude lower (0.6 OD vs 50 OD). However, it was still important to 
examine whether the gold nanorods used for NanoLipo results in any toxicity. 
Animals from the NanoLipo efficacy study were divided into two groups based 
on time-point: one month (n=3; Pigs #464, 469, 473) and six months (n=3; Pigs 391, 
392, 394), with one untreated pig serving as control (Pig #475). Urine and blood were 
periodically collected to construct the clearance profile. Animals were sacrificed at 
their respective time points and major organs were harvested and processed for ICP-
MS analysis. The UCSD Animal Care Program Staff aided in the collection of 
specimens for analysis, and a ThermoQuest Element 2 high-resolution ICP-MS 
machine at the Scipps Isotope Geochemistry Lab was used to perform the ICP-MS 
Analysis.  
Gold is Cleared from Animals after Six Months 
Injected gold nanoparticles were found to mostly clear from the bodies of pigs 
after six months. The peak concentration in the blood was measured between 10 days 
and one month after treatment. However, this peak concentration was less than 1% of 
the injected dose. This clearance profile is expected, especially for PEGylated 
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nanomaterials that are able to achieve host immune evasion.
1
 The gold in the blood 
was largely cleared after one month of residence time. 
  
 
Figure 2.3.1. Clearance profile of AuNRs from pig blood. The concentration of 
gold was maximum at approximately one month after treatment. This profile is not 
unexpected for PEGylated nanoparticles, which can avoid immune detection and 
remain in circulation for extended periods of time. This concentration was less than 
1% of the injected dose.  
 
Gold nanoparticles significantly accumulated in the liver at both one month 
and six months, which is expected since this class of materials is known to clear 
through the reticuloendothelial (RES) system.
1
 Surprisingly, gold nanoparticles also 
seemed to accumulate in the lungs of pigs. This observation may be explained by the 
aspect ratio of the nanorods, as nanomaterials with high aspect ratios are known to 
preferentially distribute to the lungs as a result of their entrapment in alveolar 
structures.
2
 Despite the presence of gold nanoparticles in the bodies of these animals 
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for up to six months, the animals demonstrated no signs of toxicity in the form of 
sickness or behavior changes.   
 
 
 
Figure 2.3.2. Biodistribution of gold in major organs of pigs after one month. After 
one month, gold was found in the liver and lungs of the animals.  
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Figure 2.3.3. Biodistribution of gold in major organs of pigs after six month. After 
six month, most of the injected gold was cleared, although some gold was still found 
in the liver and lungs of the animals.   
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Chapter III: 
 
A Single-Blind Study Evaluating the Efficacy of NanoLipo in an 
 ex vivo Human Tissue Model 
 
3.0 PREAMBLE: FUNCTION AND PHYSIOLOGY OF HUMAN ADIPOSE 
TISSUE  
Long thought to be an inert organ whose sole function was energy storage, it is 
becoming increasingly clear that adipose tissue is much more complex. Adipose tissue 
has been found to play an incredibly important role in regulating metabolic processes 
as a vital part of the endocrine system
1, 2
, with adipose tissue remodeling at the cellular 
and tissue levels being implicated in the obesity epidemic,
3
 as well as related 
pathologies of insulin resistance, metabolic syndrome, inflammation, and even 
cancer
4
. In addition, the discovery of depots of adult stem cells
5-7
 in adipose tissue 
makes it invaluable as a readily available yet inexpensive source of cells for stem cell 
therapies. Decellularized forms of the underlying adipose tissue scaffolds were also 
recently applied for adipose
8, 9
 and broader tissue engineering applications.
10, 11
 These 
factors make adipose tissue research increasingly relevant in medicine. Since adipose 
tissue was not considered to be a functional organ until recently, there was a lack of 
terminology in describing and delineating the nuances between the different types of 
adipose tissue, or “fat”, as it was colloquially referred to. As researchers grasped a 
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better understanding of adipose tissue anatomy, physiology, and function, it became 
increasingly important to consolidate the various terms used in the literature to create a 
hierarchical classification to describe adipose tissue architecture.
12, 13
 
Adipose Tissue at the Cellular Level  
The basic unit of adipose tissue at the cellular level is the adipocyte. There are 
two main types of adipocytes, white and brown. White adipocytes constitute the 
majority of adipocytes and are primarily responsible for storing excess energy in the 
form of triglycerides by packaging them into a single large lipid droplet which can 
occupy up to 85% of the cell by weight, which would not be well-tolerated in other 
types of cells.
14
 Since the droplets are so large, other cellular constituents, including 
the nucleus and various organelles, are pushed to the periphery of the cell. It was also 
recently discovered that white adipocytes play a significant biochemical role in the 
cell biology of adipose tissue expansion.
15
 The less common brown adipocyte, on the 
other hand, is comprised of multiple, smaller lipid droplets, along with an abundance 
of mitochondria, accounting for their color as well as their important role in thermo-
regulation
16
. In addition to white and brown adipocytes, adipose tissue is also 
comprised of smaller populations of endothelial cells, fibroblasts, macrophages, and 
various other cell types that play important roles in regulating and maintaining adipose 
tissue health. Generally, adipose tissues containing proportionally more white or 
brown adipocytes are referred to as white adipose tissue (WAT) and brown adipose 
tissue (BAT), respectively. 
Visceral vs. Subcutaneous Fat 
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At the macroscopic level, total adipose tissue, not including those found in 
bone marrow, the head, hands, and feet, is divided into two main compartments: 
Visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT), which are 
found inside and outside of the abdominal cavity, respectively. VAT can be further 
partitioned into various sub-compartments corresponding to the VAT immediately 
surrounding the various vital organs, as well as the VAT in the intraperitoneal space. 
VAT is relatively more active metabolically
17
 owing to the proportionally larger 
percentage of BAT compared to WAT. SAT, on the other hand, is comprised of 
mostly WAT, and is partitioned into two main sub-compartments: A superficial 
(sSAT) and a deep (dSAT) layer distributed thought various regions of the body and 
separated by a fibrous membrane referred to as Scarpa’s fascia, which has been 
observed with common imaging methods such as computer-aided tomography. The 
SAT compartment is the most relevant in the context of liposuction, since VAT is 
located deep within the thoracic cavity.  
Architectural Organization of Subcutaneous Adipose Tissue 
Subcutaneous adipose tissue is organized into complex hierarchal levels.
18
 As 
stated earlier, the smallest unit of adipose tissue is the adipocyte. Immediately 
surrounding the adipocytes are thin fibrous septa rich with proteins such as elastin, 
fibronectin, and collagen, which help the cells organize locally into micro-lobules 
measuring approximately several micrometers in diameter. An analogy used by Klein 
to describe the micro-lobule is a raspberry, in which the adipocytes are the individual 
lobes of the raspberry.
19
 The next level of hierarchical organization is the secondary 
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lobule, also sometimes called a pearl because of the surrounding transparent 
collagenous membrane which gives this structure a pearl-like luster. The analogy used 
to describe a pearl is a cluster of grapes, in which each individual grape corresponds to 
the primary lobules while the vine corresponds to the connective tissue holding the 
clusters together. Fat pearls vary in size depending on its location inside the body, but 
can be as large as 1 cm in diameter. Visually, pearls can be sliced open to reveal 
lobules that appear to be small granules of a yellowish paste-like substance. Many 
pearls are packed together into a rhomboidal prism structure known as a fat section. 
Finally, fat sections are organized in a crystal lattice–like fashion to create a fat 
compartment, such as the deep subcutaneous adipose tissue compartment. Different fat 
compartments are typically named after the area of the body in which they are located, 
e.g. abdominal or buttocks.  Digital photographs of freshly human adipose tissue can 
be found in Fig 3.1, Fig. 3.3, and Fig. 3.5. 
Obesity and The Biology of Adipose Tissue Expansion  
Adipose tissue mechanical properties, specifically plasticity and expandability, 
may be key determinants in obesity-associated metabolic dysregulation.
20
 The primary 
response of the body to over-nutrition is lipogenesis, a process by which free fatty 
acids are esterified into triglyceride molecules which are then stored inside adipocytes 
as lipid droplets. The reverse of this process is lipolysis, in which adipocytes break 
down and release stored triglycerides in the form of free fatty acids and glycerol. The 
balance between lipogenesis and lipolysis is generally controlled metabolically, 
although various environmental factors may induce lipolysis.  
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In general, during lipogenesis, white adipocytes located throughout the body in 
all adipose tissue types simultaneously increase in size by expanding their membranes 
in response to increasing amounts of triglycerides being deposited. When the cells 
reach a certain capacity, typically on the order of 100 μm or more, adipose tissue 
expansion as a whole occurs. Under healthy conditions, this process is accompanied 
by an acute inflammatory response associated with a net loss of adipose tissue 
collagen, allowing for adipocyte lipolysis (fat breakdown) followed by re-deposition 
into newly formed adipocytes. Meanwhile, dysfunctional adipose tissue expansion is 
associated with an increased number of extracellular matrix (ECM) deposits, owing to 
an inability by the body to effectively degrade ECM. The consequence of this limited 
capacity for expansion exacerbates insulin resistance as well as leads to chronic 
inflammation and hypoxia. Rutkowski et al. reviewed the mechanism of adipose tissue 
expansion in detail from a cell biology and metabolic perspective that focuses on the 
various biochemical factors involved.
15
 Nevertheless, the excess ECM deposits lead to 
changes in macroscopic mechanical properties, especially in SAT, as an indirect 
indication of adipose tissue health.   
This process of pathologic adipose tissue expansion was recently implicated in 
breast cancer tumorgenesis
4
. Obesity is known to be one of the main risk factors for 
cancer, although the mechanism was not clear. Seo et al showed that obesity induced 
pathologic adipose tissue deposition in mammary tissue resulted in increased ECM 
stiffness, which in turn promoted the differentiation of adipose stromal cells into 
myofibroblasts. Measurements of the Young’s modulus of decullarized adipose tissue 
from obese mice compared to controls showed that the stiffness was nearly double in 
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the obese group, which was verified by the longer collagen and fibronectin fiber 
networks observed in the ECM of obese mice. The newly differentiated 
myofibroblasts would then deposit even more ECM to further increase the density and 
stiffness of the ECM, resulting in a positive feedback loop that not only promoted 
tumor malignancy, but also enhanced the tumorigenic potential of pre-malignant 
human breast epithelial cells.  
All of these factors, taken together, help account for the various, complex 
sources of potential complications during liposuction. For example, the tissue history 
significantly influences the fibrousness of the tissue, and thus the difficulty of 
treatment during liposuction. Additionally, adipose tissue created during fat 
expansion, often called “resistant fat”, is extremely tough to be rid of. A specific form 
of liposuction called body contouring may aid in the removal of resistant fat. Human 
adipose tissue is also uniquely different from that of any other species, including 
porcine tissues, the best animal model substitute, so it is beneficial to model NanoLipo 
is a human adipose tissue model. The remainder of this chapter is comprised of work 
that is currently being prepared for submission for the American Society for Plastic 
Surgeon’s Aesthetic Surgery Journal. Wangzhong Sheng, William J. Seare, Ali H. 
Alhasan, Esther Cory, Paul Chasan, Robert Sah, Khalid Almutairi, Barry DiBernardo, 
and Adah Almutairi, “A Single-Blind Study Evaluating the Efficacy of Gold 
Nanoparticle Photothermal-Assisted Liposuction in an ex vivo Human Tissue Model.” 
Oxford Academic 2017. The dissertation author was the primary investigator and 
author of this work. 
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3.1 ABSTRACT 
Background: Liposuction is one of the most performed cosmetic surgery procedures. 
In a previously reported study, gold-nanoparticle (GNP) laser-assisted liposuction 
(NanoLipo) was shown to improve procedure parameters and outcomes in a porcine 
model. Objective: An ex vivo human liposuction model was developed to assess the 
ease, efficacy, and outcomes of NanoLipo, and to further explore its mechanism of 
action in facilitating liposuction. Methods: NanoLipo was compared to a Control 
without GNPs in sets of fresh, non-perfused, anatomically-symmetric, matched tissue 
specimens from twelve patients. A subset of three experiments was performed under 
single-blind conditions. Intra-operative assessments included lipoaspirate volume, 
percentage of free oil, ease of removal, and temperature rise. Specimens were 
palpated, visualized for evenness, and graded with and without skin. Post-operative 
assessment included viability staining of the lipoaspirate and remaining tissues. Micro-
computed tomography was used to assess the distribution of infused GNPs within the 
tissues. Results:  NanoLipo consistently removed more adipose tissue with more 
liberated triglycerides compared to Control. NanoLipo specimens were smoother, 
thinner, and had fewer and smaller irregularities. Infused solutions preferentially 
distributed between fibrous membranes and fat pearls. After NanoLipo, selective 
structural-tissue disruptions, indicated by loss of metabolic activity, were observed. 
Thus, NanoLipo likely creates a bimodal mechanism of action whereby fat lobules are 
dislodged from surrounding fibro-connective tissue, while lipolysis is simultaneously 
induced. Conclusions:  NanoLipo showed many advantages compared to Control 
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under blinded and non-blinded conditions. This technology may be promising in 
facilitating fat removal for well-trained and less-skilled liposuction practitioners alike. 
3.2 INTRODUCTION 
According to data gathered by the American Society of Plastic Surgeons 
(ASPS) from 2015, liposuction surgery is one of the most popular cosmetic surgery 
procedures, and is arguably the number one performed procedure because of under-
reporting by non-society affiliated practitioners. Despite its popularity, the number of 
annual procedures has fallen 37% since the year 2000.
21
 Part of the reason for this 
decline may be the relatively lower satisfaction rate reported among patients receiving 
liposuction surgery compared to other top cosmetic procedures. Rohrich, et al. 
reported that satisfaction rates were 73% and 82% for patients who either gained or 
did not gain weight post-surgery, respectively,
22
 with asymmetry, contour 
irregularities, inadequate or excessive fat removal, scarring, and residual skin laxity 
being some of the top reasons for dissatisfaction.
23
  Broughton, et al. similarly 
reported that only 79.7% of a cohort of 209 surveyed patients would elect to have the 
procedure again.
24
 These numbers leave some room for improvement, given that 
satisfaction rates as high as 98% have been reported for procedures such as breast 
augmentation.
25
 Both experienced liposuction doctors and other less experienced 
practitioners could benefit greatly if the procedure could be performed more quickly, 
while removing more fat with more forgiving and even results, especially in the 
patients with more fibrous tissue such as patients undergoing repeat procedures. 
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The objective of this study was to assess a technology called NanoLipo that uses gold 
nanoparticles (GNPs) added to standard tumescent fluid, injected into the targeted fat, 
followed by the application of externally applied near-infrared photothermal laser 
energy to create lipolysis and focused disruptions to fibro-connective tissues, while 
assisting in producing superior aesthetic results. Concepts were borrowed from 
photothermal therapy (PTT) for cancer that similarly involves the use of various 
agents capable of capturing optimally-penetrating laser energy and creating focused 
heating to lethally damage cancerous tissues.
26
 Plasmonic GNPs were chosen for this 
application because it is one of the most extensively studied photothermal agents in 
oncology. However, one major distinction from cancer therapies is that in NanoLipo, 
GNPs are injected at concentrations orders of magnitude lower than those used in 
PTT, since the goal is not complete tissue destruction.
27
 Another important distinction 
between NanoLipo and cancer therapies that rely on bulk heating is that the laser 
energy in NanoLipo is applied for strategically predetermined pulse durations and 
optimized power outputs, leveraging known heating relaxation times for the GNPs and 
affected target fat structures. NanoLipo is thereby able to specificly disrupt the 
fibroconnective tissues and lipocytes through selevtive photothermolysis.
28, 29
 The 
ability of this novel photothermal-assisted liposuction procedure to produce superior 
outcomes in many aspects was previously reported in a porcine model.
27
 While this 
model is the best alternative to human skin and fat, porcine tissues still have 
significant biological, physiological, and mechanical differences from tissues of 
human origin.
30
 In this work, the first ex vivo human tissue liposuction model was 
developed, to the best of our knowledge, to was successfully used to evaluate the 
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limitations, benefits, and efficacy of the NanoLipo technology in improving 
liposuction before proceeding with clinical trials.  
3.3 MATERIALS AND METHODS 
Adipose Tissue Harvest and Preparation for NanoLipo Treatment  
The use of human tissues conformed to the principles of the Declaration of 
Helsinki, as well as all U.S. federal guidelines and regulations.
31
 Subjects voluntarily 
undergoing combined liposuction and abdominoplasty procedures at the private 
practices of participating plastic surgeons provided informed consent for the use of 
their tissues. An institutional review board was not used for this study because 
experiments were conducted on discarded tissue and did not involve direct 
experimentation on human subjects.
32, 33
 Twelve bilaterally symmetric tissue flaps 
containing skin and a sufficient amount of adipose tissue were surgically removed 
from the lower abdomen, lateral flank, and sometimes extending to the area above the 
buttocks of subjects, and were provided, without identification, to the researchers 
(Table S1). All tissues were excised and tested on the same day and in most cases 
within a few hours to ensure tissue viability and similarity to in situ tissues. Samples 
were typically between 3 cm to 6 cm thick, 10-20 cm wide, and up to 30-36 cm in 
length per bilaterally symmetric sample when received. Except for one sample, a 
Fitzpatrick skin type VI, all samples were type III or less. A treatment zone of 
approximately 4 cm x 7 cm was identified and marked in symmetrical areas selected 
for lack of stretch-marks, hair, and scars, with matched even consistency, texture, and 
pigmentation of the skin. A larger non-treatment region of 2-3 cm, at minimum, was 
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included on all sides of the treatment zone to minimize loss of infused tumescent 
solutions out of the exposed edges, to ensure even vacuum and application of the laser, 
and to serve as handles for the specimen during liposuction while keeping the 
tumescent and liposuction cannula tips in the treatment area. All samples were 
immediately post-processed and analyzed after treatment. 
NanoLipo Procedure 
In our model, NanoLipo involved the infusion of 40 cc of GNP-containing 
phosphate buffered saline (PBS) solution injected into the interstitial spaces of adipose 
tissue in the targeted treatment zone using standardized tumescent and instrumentation 
techniques.  The Control contained no GNPs in the tumescent solution. The GNPs 
were surface-functionalized with a passivating poly(ethylene-glycol) (PEG, 5 kDa) 
polymer coating to prevent clumping and to improve tolerability by biological tissues 
(NanoSpectra BioSciences, Inc., Houston, TX).
34
  The stock 50 optical density (OD) 
GNPs provided was diluted with PBS to down to 1.2 OD before infusion into tissue 
specimens. GNP size, aspect ratio, and other physical, and optical properties were 
confirmed to be as indicated by the manufacturer.  
A tumescent infiltration protocol was developed and instituted in an attempt to 
maximize the even disbursement of the GNP within the treatment zone. A 2 mm x 130 
mm multi-port infusion cannula was inserted parallel to and approximately 1-3 cm 
below the skin surface, approximately the maximum depth of light penetration.
35
 The 
cannula was inserted fully into and through the tissues to the distal edge of the 
treatment zone. The tumescent or GNP solution was introduced into the tissues only 
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during withdrawal of the cannula to the proximal edge of the treatment zone, injecting 
approximately 1 cc per pass with 10 passes per side. This process was repeated as 
multiple and separate introductions from all four sides for a total tumescent infusion of 
40 cc. Every attempt was made to infuse the solutions evenly while manually locating 
and digitally guiding the cannula within the specimen.  
For the laser energy application, the 4 cm x 7 cm tumesced treatment zone was 
exposed to the laser through the skin in a pre-determined application pattern in an 
attempt to maximize the even distribution of the laser energy within the treatment 
zone. A commercially available 800 nm pulsed diode laser (Lumenis LightSheer® 
DUET
TM
, Lumenis Ltd. Yokneam, Israel) was used for all studies. The laser was set to 
generate passes comprised of three consecutive pulses of 30 ms duration, at an energy 
density of 6 J/cm
2
 (46 J/ pulse; 138 J/pass) through its 22 mm by 35 mm exposure 
area. A total of twelve consecutive effective passes were administered, for a total of 
~1650 J of energy per treatment area. Mild vacuum, a built-in function of the machine, 
was applied during the laser treatment. The skin surface temperature was monitored 
periodically with a thermal camera (FLIR E50; FLIR Systems, Wilsonville, OR). A 
cool dampened towel (~10 °C) was placed over the treated region every two passes for 
ten seconds, or more often if needed, to cool the skin surface. A thermocouple was 
periodically placed approximately 2 cm parallel to and below the skin surface, through 
one of the exposed edges of the tissue, to measure the internal bulk temperature. The 
same pre-liposuction treatment procedures were administered to both the Nanolipo 
and the Control group, with the only difference being the presence or absence of GNPs 
in the infusion solution, respectively.  
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To perform the liposuction, a standard fat harvesting/transfer multi-port 
cannula (Tulip Medical, San Diego, CA) was connected to a commercially available 
liposuction vacuum pump (Grams, Newport Beach CA) and set to 28 mmHg. 
Liposuction was first performed in the Control, then in the NanoLipo specimen. 
Liposuction was performed for a defined amount of time (30 sec – 1 min), and varied 
depending on the initial amount of aspirate from the first sample from the Control 
group so that the target volume of about 40 cc would be harvested and be about the 
same as the amount used during tumescent infiltration. The time to suction the 40cc 
for the Control group was then used for the NanoLipo group. The liposuction 
procedure was performed similarly to the tumescent solution infiltration procedure, 
with suctioning from all four sides into the treatment zone as evenly as possible and 
with similar effort. For the last three specimens, practitioner 1, who had conducted the 
previous experiments under non-blinded conditions, performed both the NanoLipo and 
Control pretreatments. Practitioner 2, an experienced board certified plastic surgeon 
with his primary practice in liposuction surgery, performed the liposuction procedures 
and made clinical determinations under blinded conditions between the NanoLipo and 
Control specimens, regarding ease of liposuction, amount and speed of lipoaspirate 
harvest, and evenness of fat removal.  Digital photographs detailing the protocol for 
this ex vivo human tissue liposuction model can be found in Fig. 3.S1. 
Post-Treatment Assessments 
The criteria used to assess clinical treatment outcomes in the tissue remaining 
after liposuction was manual palpation and visual inspection. During manual 
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palpation, the practitioner applied gentle digital pressure on the skin over the treatment 
zone to assess for the amount and evenness of fat removal. A comparison of evenness 
and any lumps or unexpected divots was made between each NanoLipo treated 
specimen and its bilaterally-matched Control. A pinch test was subsequently 
performed to further assess for the smoothness and evenness within the treatment 
region. After these initial assessments, the skin was surgically removed from the 
subcutaneous fat with a scalpel blade, much like harvesting a full-thickness skin graft, 
leaving only the liposuctioned fatty tissues behind. Inspection, palpation, visual 
determinations, and rank ordering of clinical criteria were completed using before and 
after skin-removal assessments by Practitioner 2. Digital photographs of the specimens 
and underlying adipose tissue were taken to document the achieved results. Surgical 
forceps were used to stretch and manipulate the post-liposuction specimens to aid in 
the inspection and visualization of the treatment outcomes. 
Lipoaspirate was collected directly into conical centrifugal tubes within the 
suction canister and gently centrifuged at 1,000 RPM for 5 min to standardize the 
settling and separation of three distinct volume fractions. The top fraction contains the 
liberated triglyceride oils, the middle layer contains intact adipose tissue and cells with 
trapped free oil, and the bottom layer contains the tumescent fluid, blood cells, plasma, 
and stem cells. The middle layer was isolated and treated with collagenase type I 
(powder, from Clostridium histolyticum) to digest the connective tissue and liberate 
the adipocytes and any remaining oil. The released fat cells were then stained with a 
Calcein/Ethidium Homodimer live/dead assay to assess cell viability. This digestion 
and staining was performed by following standard protocols provided by the supplier 
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(all reagents and kits purchased from Thermo Fisher Scientific, Waltham, MA). 
Optical microscopy was used to image the cells and tissues.  
In a related experiment, the viability of intact adipose tissue remaining after 
liposuction was assessed with Nitroblue Tetrazolium Chloride (NBTC) staining, as 
previously reported.
28, 36
 Briefly, NBTC is a dye that stains for mitochondrial activity 
such that metabolically active tissue will be stained a deep-blue color while 
photothermal-induced reduction of metabolic activity would lead to loss of staining. A 
thin tissue slice approximately 1.0 cm thick bisecting the treatment region along the 
vertical laser beam axis was isolated, stained, and photographed. To assess the 
distribution of infused GNP solution, a micro-Computed Tomography scanner (µCT, 
Skyscan 1076, Kontich, Belgium) was used to image adipose tissue specimens that 
were either injected or not injected with solution. A calibration curve involving air, 
adipose tissue, saline, and various concentrations of GNPs was constructed to help 
identify the structures imaged. Imaging was performed at 18 μm isotropic voxel size at 
an electrical potential of 50 kVp and current of 200 μA using a 0.5 mm aluminum 
filter with a beam hardening correction algorithm applied during image 
reconstructions. 
3.4 RESULTS  
Assessment of Treatment Outcomes under Non-Blinded Conditions 
During the tumescent step, no differences were seen between the NanoLipo 
and the Control saline only groups. During the laser treatment step, there was a 
minimal rise in the skin temperature of approximately 10°C in the Control group after 
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the complete 12 passes, while in the NanoLipo group, the skin surface temperature 
typically rose quickly after only a few passes (Fig. 3.2A). The most significant heating 
was observed at the skin surface in non-study pilot experiments for the NanoLipo 
group when towel cooling was not performed, with temperatures exceeding 40 °C or 
more at local hot spots matching the pattern of the diodes in the laser aperture after 
each pass that would quickly equilibrate with the surrounding tissue. The heating was 
significantly mitigated with towel cooling, although the hot spots were still observed. 
In the Control group, skin surface temperature never exceeded 40 °C regardless of 
whether towel cooling was performed or not. Additionally, thermocouple readings for 
internal bulk temperature for the NanoLipo group barely exceeded 30 °C at the end of 
twelve passes, while the internal bulk temperature for the Control group was 
unchanged from the starting temperature.  
During the liposuction step, in general, the NanoLipo treated specimen 
appeared to be better liposuctioned and more evenly reduced than the Controls. In 
thicker samples, the practitioners most often found a clinical difference in the ease 
with which the suction cannula moved to remove the fat for the NanoLipo group, as 
well as an increased rate at which fat was removed compared to the Control. 
Practitioner 1, a non-plastic surgeon researcher, on average rated the NanoLipo and 
Control procedures 5/10 and 7/10 in terms of difficulty, respectively, on a scale of 1 to 
10 with one being very easy and ten being very difficult. Practitioner 2, a trained 
plastic surgeon, on average rated the NanoLipo and Control procedures 4/10 and 5/10 
in terms of difficulty, respectively, on the same grading scale. Both practitioners noted 
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that the improvement in the ease of suction was markedly greater for more fibrous 
specimens.  
The immediate appearance of the NanoLipo treatment area was the presence of 
a clearly defined depressed region approximately matching the shape and size of the 4 
cm x 7 cm laser treatment area (Fig. 31A, dashed rectangle). This feature was only 
occasionally present, and to a much lesser extent, in the Control specimens (Fig. 
3.1B). In some thinner specimens, nearly all of the adipose tissue within the treatment 
zone was removed for the NanoLipo group, resulting in a full-thickness void spanning 
most of the sample (Fig. 3.S2). In the Control treatments, this full thickness tissue 
removal was not seen and the indentations were always to a lesser extent. When 
visually examined from the deep side (turned up-side-down), or when the skin was 
surgically removed from the specimens, the NanoLipo treated specimens were more 
uniform, smoother, and had proportionally more fibrous tissue strands exposed, with 
fewer lumps and smaller, and much finer residual fat lobules compared to Control, as 
can be clearly seen in Fig. 1C and 1D, respectively.  
After the lipoaspirate was centrifuged, three distinct volume fractions were 
observed. The free fatty triglyceride oil volume fraction was situated at the top in the 
NanoLipo treated lipoaspirate. In some cases, it accounted for nearly half of the total 
lipoaspirate tissue and oil volume (not including the aqueous phase), while this 
fraction was practically non-existent in the Control lipoaspirate (Fig. 3.2B). Liberated 
triglycerides were consistently observed for NanoLipo treated specimens, as clearly 
seen in the liposuction tubing in Vid. 1. Liberated triglycerides in the NanoLipo 
treated specimen were even observed for the single high-Fitzpatrick skin type 
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specimen that was tested (Fig. 3.S4). Adipocytes isolated from the middle fatty tissue 
volume fraction were viable, as indicated by the green staining imparted to the cells 
(Fig. 3.2C).  
Assessment of Treatment Outcomes under Single-Blind Conditions 
Clinical assessment of the NanoLipo versus the Control treated specimens was 
undertaken. In a single-blind series with three consecutive cases, Practitioner 2 noted 
that one of the specimens was markedly thinner and had significantly fewer lumps 
after suctioning. After skin removal, the specimen that was thinner was also much 
smoother within the treated region. Fig. 3 displays a representative comparison 
between two blinded specimens from one set of tissues. As shown, the NanoLipo 
specimen is smooth, even, and has smaller fatty lobules (Fig. 3.3A) while the Control 
specimen has many large fat lobules and pearls clearly visible throughout the region 
(Fig. 3.3B). A demarcation (dotted line) that matched well with the edge of the 
treatment zone was observed in the NanoLipo treated specimen, beyond which 
distinctive large fat pearls similar to those found throughout the Control specimen are 
clearly observed (arrows). Practitioner 2 noted that the first blinded specimens 
(NanoLipo) was marginally easier to suction than the second (Control) and that the 
former (NanoLipo) had regions where the difficulty of suction was significantly 
reduced. Although Practitioner 2 indicated that he would not have been comfortable 
making a determination based on the ease of suction alone, he was able to identify the 
NanoLipo treated specimen correctly based on the obvious visual and physical 
differences after suctioning.  
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NanoLipo Mechanism Investigations 
Upon infusion into adipose tissue, photothermal solution expanded the 
interstitial spaces between the connective tissue membranes separating pearls of fat. 
Fig. 3.4A, 3.4C, 3.4E, and 3.4B, 3.4D, 3.4F respectively show the sagittal, transverse, 
and coronal views of µCT images of tissue specimens that were or were not infused 
with GNP photothermal solution. The relatively darker spaces represent air, the 
relatively grey spaces represent fat-rich regions, and the relatively white spaces 
represent water-rich regions. Scarpa’s fascia can be seen in the transverse and sagittal 
views as a relatively thicker white line parallel to the skin surface. In Fig. 4A, 4C, and 
4E, connective tissue regions have been expanded by infused solution while the same 
connective tissue separating pearls of fat in the un-injected Control specimen remains 
collapsed. The expanded regions were, in some cases, up to 2 mm in size. Consistent 
with the observed distribution of photothermal solution, there was a loss of staining in 
some regions of the NanoLipo treated specimen (Fig. 3.5A, arrows), whereas the 
whole specimen was stained a deep-blue color for the Control specimen.  
3.5 DISCUSSION 
We previously reported the ability of NanoLipo to produce aesthetically 
superior results compared to saline in our porcine model.
27
 These promising results 
motivated us to develop an ex vivo human liposuction model to investigate whether 
NanoLipo could be successfully used as an adjunct for fat removal in human tissue 
specimens before proceeding with human clinical trials. One of the distinctive findings 
in the current study was the presence of liberated triglycerides in the lipoaspirate of 
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NanoLipo treated specimens before any post-processing (Fig. 3.2B, left). We 
speculate that a specific form of the photothermal effect, called selective 
photothermolysis (SPT), may be the mechanism responsible.
29, 37
 Briefly, SPT posits 
that short bursts of light applied over a wide area can selectively and precisely heat up 
pigmented target structures based on their geometry without significant heating of the 
surroundings. For example, a 3 ms pulse of light can be used to preferentially heat 
spherical targets with diameters 100 µm or smaller, while a 300 ms pulse can heat 
structures up to 1 mm.
37
 Incidentally, adipocytes, as well as some of the fibrous 
membrane support structures in adipose tissue, are between 100200 µm in their 
native state. Thus, they may be readily targeted by this selective photothermal 
phenomenon. We believe that this principle, which has been successfully applied to 
target the melanin in hair follicles during laser hair removal,
38
 can be applied to 
liposuction, as well. 
The first observation in support of this mechanism is the lack of significant 
bulk heating in the adipose tissue of the NanoLipo treated group (Fig. 3.2A). The most 
significant heating for both the NanoLipo and Control specimens was observed at the 
skin surface. For the measurements used to construct the heating profile in Fig. 3.2A, 
the thermal camera was aimed at the local hot-spots in the pattern generated by the 
laser aperture, which were typically at least 10 °C hotter, or more, than the 
surrounding tissue. This inhomogeneous heating was manageable when a damp towel 
was used to immediately cool the surface after laser exposure to quickly thermal-
equilibrate the hot-spots with the surrounding tissue to prevent the temperature from 
exceeding 40 °C for an extended period of time. Heating of the skin surface may be 
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mitigated with the use of a chilled applicator. These results are consistent with what is 
historically regarded as the greatest limitation in laser-based biomedical applications, 
i.e., the limited penetration depth of light into tissue.
35
 Even wavelengths of light in 
the middle of the biological optical window around 800 nm, which was specifically 
chosen for this application, can penetrate only a few centimeters into tissue at 
maximum. Nevertheless, the light that does successfully penetrate the skin seems to be 
sufficient in producing a photothermal effect, as evidenced by the presence of 
liberated triglyceride even in the specimen with the highest Fitzpatrick skin type, 
which would have the lowest amount of light energy irradiating the GNPs within the 
fatty tissues among all of the tested specimens (Fig. 3.S4). 
Another clue for the mechanism of NanoLipo may be the way that infused 
GNP solution distributes within adipose tissue. Adipose tissue is organized into 
several hierarchical levels.
39
 At the lowest level are the adipocytes, which are packed 
into lobules that are further nested within larger structures, called pearls. Many pearls 
packed together to form a section, such as the superficial or deep subcutaneous 
adipose tissue sections that are separated by a thick membrane called Scarpa’s fascia. 
In Fig. 4, µCT images showed that the infused GNP fluid preferentially distributed 
between and expanded the interstitial spaces between fat pearls. This result is 
expected, since it would be unfavorable for the hydrophilic GNP fluid to be well-
mixed with the highly hydrophobic fat regions of adipose tissue. Upon exposure to 
external pulses of light through the skin, these photothermal fluid-filled compartments 
are heated up preferentially, which is supported by the loss of metabolic activity 
shown by NBTC staining precisely at this structural level (Fig. 3.5A). Additionally, 
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the deep blue color expressed throughout the remainder of the NanoLipo treated 
specimen indicates that full-thickness fat loss does not occur and that selective damage 
occurs only where the photothermal agents are deposited, while staining in the entirety 
of the Control specimen (Fig. 3.5B) indicates that the laser is well tolerated.   
These results taken together suggest a mechanism by which thermal stress 
imparted to the connective tissue network surrounding and intertwined within adipose 
tissue weakens those structures, while also acting to disrupt the lipocytes themselves, 
thus facilitating the removal of both the fat and parts of the fibrous tissue support 
structure during liposuction. The photothermal heating imparted to the tissue likely 
extends beyond the fibrous tissue membrane level through conduction, and may 
induce thermal lipolysis. We believe that it is this lipolysis that is responsible for the 
difference in liberated triglycerides we observed between the NanoLipo and the 
Control.
40
 This specific mechanism we propose is consistent with all of the 
observations presented in this study, i.e., the presence of liberated triglyceride and the 
lack of large fat pearls accompanied by the thinner and smoother appearance for the 
NanoLipo treated specimens.  
The photothermal phenomenon, which has been studied extensively in the 
context of cancer therapy
26
, has only been sparsely explored in humans or human 
derived specimens. In one study, Tuchin et al. stained thin human adipose tissue 
sections with a photothermal dye, indocyanine green, and exposed the specimen to 
over three hours of light exposure. The continuous and long-term exposure eventually 
resulted in “destructive engineering” of adipose tissue, but certainly cannot be applied 
realistically or practically in the context of liposuction.
41
 Another study involves the 
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investigation of a 1060 nm pulsed Nd:YAG laser administered through the tip of fiber 
optic cable attached to a liposuction cannula, for laser lipolysis through photothermal 
heating of resident water in tissues.
42
 The one-dimensional point-source nature of the 
laser aperture does not produce uniform heating when it is used to cannulate adipose 
tissue. Another limiting factor of this method is that the resonance wavelength is tuned 
to optical absorption of water molecules in tissue, which means that significant care 
must be taken not to overheat the targeted or non-targeted tissues. In fact, significant 
carbonization of adipose tissue was often observed as a result of this treatment.
42
 
Therefore, although this technology has been approved by the FDA and marketed as 
SmartLipo (Cynosure, Westford, MA),
43
 it has not gained popularity among plastic 
surgeons due to its lack of efficacy and no demonstrable improved result over 
traditional liposuction techniques, with the added potential for thermal injury. In 
contrast, NanoLipo treatment overcomes this shortcoming by applying the light energy 
in a two-dimensional nature over the target area that is infused with GNPs, resulting in 
uniform and even heating of the adipose tissue, as was demonstrated in this study. 
Additionally, one question that was unanswered at the time of the porcine study was 
whether the injected nanoparticles induced any potentially harmful side-effects. We 
have since conducted a six-month biodistribution and biocompatibility study to assess 
any toxicity concerns based on the finding that the majority of nanoparticles are 
eliminated from the bodies of pigs, and that the minuscule amounts of residual 
particles exhibit no observable signs of toxicity in our porcine model and with other 
studies.
44
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Ultimately, the outcome of liposuction surgery depends, first and foremost, on 
the provider experience, skill, and training.
23
 Other factors, such as patient tissue 
history, including repeat procedures, scarring in the treatment area, or the location on 
the body
45
, as well as the amount of time and care taken, and the amount of tissue to 
be removed, all play important roles. However, even for highly trained plastic 
surgeons, significant time, effort, and attention to detail are needed to carefully suction 
the tough to treat fibrous or large areas to produce aesthetically pleasing results. Many 
plastic surgeons opt to perform two or more rounds of suctioning within the same 
session, with latter rounds involving the use of finer cannulas to extract the tough fat 
residing within especially fibrous pockets of connective tissue that lead to the 
formation of lumps and bumps post-treatment if left unaddressed.
39
 In the current 
study, the practitioners were allotted at most only a few minutes to perform the 
simulated liposuction without multiple rounds of suctioning using finer cannulas. We 
believe and have substantiated with our data that NanoLipo treatment was able to 
generate superior outcomes compared to the Control.  If these results can be 
extrapolated to larger treatment sizes in clinical settings, we believe the photothermal 
pre-treatment process of NanoLipo applied to liposuction may be a useful tool for 
liposuction practitioners. 
 
 
3.6 CONCLUSION 
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Our goal in this study was to investigate NanoLipo primarily as a technique to 
hasten, facilitate, and improve the liposuction procedure and outcomes. Based on the 
observed results, we have shown that photothermal pretreatment of adipose tissue is 
effective in assisting the more rapid and efficient removal of fat while producing 
aesthetically superior outcomes compared to conventional suction assisted lipectomy 
in excised human tissue specimens. We believe that with this current data in hand, our 
next step is to evaluate NanoLipo in human clinical pilot studies while examining its 
short-term and long-term indications, advantages, results, and potential complications.  
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3.10 FIGURES 
 
Figure 3.1. NanoLipo procedure results in the removal of visibly more fat, 
indicated by A. A clearly visible depressed region within the underlying adipose tissue 
matching the shape and size of the laser aperture (dotted rectangle). B. The same 
feature is not present in the Control (saline + laser + liposuction) treated specimen. C. 
Proportionally more fibrous tissue is observed in the NanoLipo treated specimen with 
very few fat lobules remaining, while. D. many fat lobules adhering tightly to the 
connective tissue membranes are observed for the Control specimens. 
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Figure 3.2. A. Heating profiles of tissue specimens for NanoLipo and Control pre-
treatments, measured externally and internally for NanoLipo, and externally only for 
Control. The NanoLipo external temperatures were recorded for local hotspots 
matching the pattern of the laser diode. Both NanoLipo internal measurements and 
Control skin surface measurements showed mild heating, while NanoLipo external 
measurements showed the most heating. B. After centrifugation, the liberated 
triglyceride phase accounted for nearly 50% of total lipoaspirated tissue volume for 
the NanoLipo group (left tube), while almost no liberated triglyceride was observed in 
the Control (right tube). C. Calcein/ethidium homodimer live/dead assay; tissue 
fluorescing green from the calcein dye shows that the majority of the tissue is viable, 
while minimal red staining, indicative of dead cells, was observed. 
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Figure 3.3. (Screen Shot) Liberated triglyceride in lipoaspirated tissues are a 
hallmark of the NanoLipo procedure. Triglycerides liberated as a result of 
NanoLipo treatment flows through a suction tube for a NanoLipo treated specimen 
compared to lipoaspirate from conventional suction-assisted lipectomy. 
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Figure 3.4. Smoothness within the treatment zone was used as a key marker to 
distinguish the NanoLipo treated specimen from Control specimens under 
blinded conditions. Digital photographs for one set of blinded experiments showing 
adipose tissue after liposuction and skin removal are shown. A. NanoLipo treated 
specimen was even in appearance and was absent of fat lobules, whereas in B. large 
and lumpy fat lobules are clearly visible and can be felt throughout the Control 
specimen. Near the edge of the NanoLipo specimen outside of the treatment zone 
(below the dotted line in A.), several large fat pearls are clearly visible (arrow). 
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Figure 3.5. Micro computer-aided tomography images of the distribution of infused 
GNP solution within adipose tissue compared to non-injected Control. A., B. show the 
sagittal views, C., D. show the transverse views, and E., F. show the coronal views of 
injected and non-injected adipose tissue specimens, respectively. The relatively darker 
spaces represent air, the relatively grey spaces represent fat-rich regions, and the 
relatively white spaces represent water-rich regions of adipose tissue, such as 
connective tissue membranes. Infused solution preferentially disperses between and 
expands into the interstitial spaces between fat pearls (A., C., and E.), while the 
interstitial spaces between connective tissue of non-injected adipose tissue specimens 
remain collapsed in their native state (B., D., and E.). Scarpa’s fascia can be seen in 
the transverse and sagittal views as a thicker white line parallel to the skin surface.  
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Figure 3.6. Absence of nitroblue tetrazolium staining (arrows) shows selective 
thermal damage of connective tissue membranes at the fat pearl level in adipose tissue 
due to photothermal inactivation of intracellular reductases, and is consistent with the 
way GNP solution distributes within iinterstitial spaces of adipose tissue. Specimens 
were subjected to A. NanoLipo or B. Control treatment, vertically bisected with a 
surgical scalpel through the optical exposure axis to isolate thin slices approximately 
0.5 cm thick, and stained. Complete staining of the Control specimen, as well as 
staining of the overlying skin and deeper adipose tissue regions in the NanoLipo 
treated specimen, demonstrates that these tissues were unaffected and that 
photothermal damage was selectively restricted to the fibrous connective tissue 
membranes at the pearl level.  
  
167 
 
 
 
Figure 3.S1. An ex vivo human tissue model was developed to test the ability of 
NanoLipo pretreatment to aid liposuction. The NanoLipo procedure involves 
infusion of gold nanorod solution into adipose tissue, followed by exposure to laser 
pulses matching the resonant wavelength of the nanorods at 800 nm through the 
surface of the skin, to heat and melt fat to facilitate its liberation and removal during 
liposuction. A. The set of tools, including infusion and suction cannulas, used for this 
study. B. A specimen approximately 3-4 cm thick with a treatment zone marked for 
treatment. C. An external laser was applied to the specimen; inset – surface 
temperature was monitored with a thermal camera to insure that temperatures did not 
exceed 40 ᵒC. D. Simulated liposuction was performed on excised tissue specimens for 
specified amounts of time for the NanoLipo and control groups. 
 
 
 
A B 
C D 
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Figure 3.S2. Thin tissue specimens with skin removed after treatment. A. A void 
spanning the full thickness of the adipose tissue was observed for the NanoLipo 
specimen after skin removal, while B. the treated region was only slightly depressed 
for the control specimen. 
 
  
Figure 3.S3. Thicker tissue specimens exhibited large indentations in the skin 
after treatment despite equal effort being exerted evenly throughout the treatment 
region. Indentations from two different tissue specimens are shown. 
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Figure 3.S4. A. A set of high Fitzpatrick skin-type specimen were treated. 
Aggressive towel cooling had to be performed to ensure skin surface temperatures 
remained low. B. Liberated triglyceride (arrow) was observed in lipoaspirate of the 
NanoLipo treated specimen (left tube), while none was observed in the control 
lipoaspirate (right tube).  
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Table 3.1. Physical characteristics of specimens tested. 
 
